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ABSTRACT
Generalized anxiety disorder (GAD) is very prevalent in the United States with 5.7% of citizens
affected (National Institute of Mental Health [NIMH], 2017). This number is expected to be even
higher because individuals avoid care due to stigma of mental illness (Andrews et al., 2018).
GAD can have significant implications such as decreased ability to function, decreased quality
of life and increased risk of suicide (Fong, 2018; Lizarondo, 2018). The purpose of this project
was to improve outcomes for adult patients with GAD in the primary care setting by improving
treatment to follow best practice recommendations. The Johns Hopkins Evidence Based
Practice Model was utilized as a guide throughout this project. After a thorough literature
search, it was concluded that best practice for treatment of GAD is with a protocol of a
combination with education provided through written and verbal transmission, cognitive
behavioral therapy (CBT) via smartphone application (app) and pharmacologic therapy via
aselective serotonin reuptake inhibitor (SSRI). This protocol was initiated among patients at a
rural family practice office in Northeast Indiana. The patients’ anxiety and depression symptoms
were measured via the Generalized Anxiety Disorder 7-item (GAD-7) scale and Patient Health
Questionnaire (PHQ-9) at baseline, and at weeks 4, 6 and 12. A one-way repeated measures
analysis of variance (ANOVA) was conducted to analyze scores and found statistically
significant differences in anxiety (F (3,39) = 6.992, p < .001) and depression (F (3, 39) = 8.867,
p < .000) symptoms from baseline (M = 12.5714, SD = 6.51288; M = 12.4286, SD = 7.70329)
to eight weeks (M = 5.2857, SD = 4.26846; M = 4.7143, SD = 4.51372) and from baseline to 12
weeks (M = 6.1429, SD = 5.88162; M = 4.6429, SD = 5.25660). Primary care providers are
encouraged to treat patients with GAD utilizing education, CBT via smartphone app, and SSRIs
due to the protocol’s cost-effectiveness, accessibility, and efficacy.
Keywords: GAD, evidence-based practice, CBT, SSRI, education, protocol
IX
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CHAPTER 1
INTRODUCTION
Background
Generalized anxiety disorder (GAD) is a very common disorder that is often addressed
in the primary care setting (Andrews et al., 2018). GAD can be defined as chronic, excessive
worry and stress associated with clinically significant distress and functional impairment. This
disorder is often accompanied by physical symptoms such as insomnia, restlessness, muscle
tension and fatigue (Love & Love, 2019). The Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition (DSM-5) provides diagnostic criteria for GAD that can be used as a
guideline to ensure correct diagnosis (American Psychiatric Association, 2013). The adult
patient must have excessive worry with at least three other symptoms on a majority of days for
at least 6 months (American Psychiatric Association, 2013). GAD may result from abnormal
serotonergic and noradrenergic neurotransmitter activity and cortisol systems (DynaMed, 2018).
Although, genetic and lifestyle factors can also play a role in disease formation. Of adults in the
United States, GAD is more common in females (3.4%) than males (1.9%) (National Institute of
Mental Health [NIMH], 2017). There is also a higher incidence in Caucasians. Patients who
have family history of GAD, have history of trauma or abuse, and those with a high level of
stress are more at risk of developing GAD (DynaMed, 2018). Individuals with poor family
support or other comorbid psychological conditions such as substance use disorder or major
depressive disorder have decreased remission rates (DynaMed, 2018). Most cases of GAD
begin in early adulthood. Median age of onset is 30 years of age in adults. There is usually
another upswing of cases that occurs at older adulthood that can be linked to chronic medical
illnesses (DynaMed, 2018).
GAD can cause serious debilitation and impact on quality of life. Out of the results from
one survey, an estimated 32.3% of adults with GAD had serious impairment (NIMH, 2017). This

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

2

impairment can come in the form of inability to perform routine tasks, decreased productivity,
lack of sleep, and impairment of personal relationships. GAD can have serious consequences
such as an increased risk of suicide (DynaMed, 2018). 37.6% of patients with lifetime GAD
attempted suicide as compared to 4.2% of people without GAD (Fong, 2018). This disease can
go beyond just psychological consequences as patients with GAD have also been shown to
have increased rates of cardiovascular related mortality (DynaMed, 2018).
Data from the Literature Supporting Need for the Project
Primary care is often the place where patients first go when they decide to seek
treatment for their anxiety disorder. It is estimated that 15-20% of patients in primary care
settings meet the criteria for anxiety disorders (Love & Love, 2019). Often, they can present with
physical symptoms that are often vague, which can make it hard for primary care providers to
make a correct diagnosis (Slee et al., 2019). Patients with GAD are two times more likely than
the general population to present initially with somatic complaints (Love & Love, 2019). Further,
many psychiatric disorders are often somewhat similar and can occur concurrently, increasing
the complexity of diagnosis (Andrews et al., 2018). Often times, anxiety goes unrecognized in
the primary care setting (Andrews et al., 2018). Adults with untreated anxiety disorders miss on
average 24.7 days of work per year due to the diagnosis (Love & Love, 2019). Untreated GAD
can contribute extensively to health care costs. In the United States, societal costs of GAD are
estimated to be 48 billion dollars per year (Love & Love, 2019). Some primary care providers
may be reluctant to treat GAD as they are unfamiliar with the treatment or would feel more
comfortable referring to a psychiatrist. Often, when treated in the primary care setting, GAD is
not treated appropriately according to the guidelines and is often undertreated (Ministry of
Health, 2015). However, the primary care setting is an appropriate setting for most cases of
GAD (Andrews et al., 2018)
National Data
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GAD is prevalent in the United States as well as other countries. Approximately 5.7% of
adults in the United States have experienced generalized anxiety disorder (National Institute of
Mental Health [NIMH], 2017). This number is assumed to be actually higher due to fact that
approximately one third of affected patients seek treatment (Edmund & Sheppard, 2018) due to
stigma or other barriers (Andrews et al., 2018). When they present to the primary care setting,
providers need to be equipped with the knowledge and resources that they need in order to
diagnose and treat the patient properly.
Data from the Clinical Agency Supporting Need for the Project
This evidence-based practice (EBP) project was conducted at a family practice clinic in
Northeast Indiana. The clinic is part of a small healthcare system and has three providers in the
office, two nurse practitioners and a physician. There are at least seven different medical
assistants or nurses providing care on any particular day. All three providers and the office
manager approved the EBP project. One nurse practitioner served as the site facilitator. Clinical
agency data were provided by the office manager. The clinic is located in a rural town with a
population of 8,732 people in 2019 (United States Census, 2019). Approximately 95.5% of
those individuals are Caucasian. Most (76.5%) citizens of the town have an Internet
subscription. The number of residents with a high school diploma is approximately 86.8%
(United States Census, 2019). The clinic sees all ages of individuals from birth to death.
The site facilitator mentioned that the practice in general writes an abundance of
benzodiazepine prescriptions for patients, and that all three providers were looking to improve
the care of patients with anxiety disorder (A. Reitz, personal communication, July 8, 2020).
There are a significant number of patients treated with anxiety disorder in the practice. In fact,
800 different patients were seen for GAD from January 2018 to September 2020 at this family
practice clinic. There were 1,809 visits during that time frame evaluating and treating those
patients for GAD. None of the charts that were reviewed mention CBT specifically, but may be
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assumed when the patient is referred to psychiatry. One of the providers discussed that a big
challenge is the patient’s preference to “take a pill and feel better” instead of pursing things like
psychiatric referral, counseling, or cognitive behavioral therapy (CBT) (B. German, personal
communication, July 8, 2020). This Doctor of Nursing Practice (DNP) project could reduce the
need for benzodiazepine usage, increase quality of life for patients, and decrease symptoms for
patients.
Purpose of the Evidence-Based Practice Project
The purpose of this EBP project was to improve outcomes for adult patients with GAD by
improving treatment to follow best practice recommendations. This was be done by providing a
protocol that includes a combination of education, digital CBT and SSRI therapy to deliver
evidence-based treatment to patients with GAD. The project aimed to decrease uncertainty of
providers, improve consistency of care in the best practice for treatment of GAD while
decreasing symptoms of GAD for patients.
PICOT Question
This project addressed the following PICOT question: Among adult patients presenting
with generalized anxiety disorder (GAD) in the primary care setting (P), does the introduction of
a protocol consisting of treatment with education via a written handout, a selective serotonin
reuptake inhibitor (SSRI) and digital cognitive behavioral therapy (CBT) via smartphone
application (app) (I) compared to current practice of no protocol (C), improve GAD symptoms as
measured by patient-reported scores on the Generalized Anxiety Disorder 7-item (GAD-7) scale
and Patient Health Questionnaire 9-item (PHQ-9) scale (O) over a 12-week period (T)?
Significance of the EBP Project
GAD is a very prevalent, severe disease that can often be debilitating and can cause
negative health outcomes (Edmund & Sheppard, 2018). There is a stigma associated with
mental illness that can cause patients to avoid receiving treatment (Edmund & Sheppard, 2018).
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More education on GAD can help to decrease stigma by increasing awareness of this issue and
by making patients aware that they are not alone (Ministry of Health, 2015). Patients present to
the primary care setting in distress and want some relief of their symptoms. Primary care
providers are more readily accessible than specialists’ offices and have been found to be an
appropriate setting to diagnose and treat GAD (Andrews et al., 2018). This project aimed to
implement a practice change based on current, high quality evidence-based practice
recommendations in the primary care setting. This practice change involved a protocol with
education, CBT via smartphone app and SSRI pharmacotherapy. Application of this protocol
helped primary care providers to gain knowledge regarding diagnosis and treatment of GAD and
guide treatment that is based on best evidence. Use of the protocol can decrease patient’s
symptom severity, increase quality of life, and decrease the rate of suicide and cardiovascular
disease (DynaMed, 2018; Fong, 2018). These improved outcomes can allow patients to return
to a productive, fulfilled and healthy life.

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

6

CHAPTER 2
EBP MODEL AND REVIEW OF LITERATURE
Evidence-based Practice Model
Overview of EBP Model
The Johns Hopkins Nursing Evidence-based Practice Model (JHNEBP) was selected to
act as a guide for this EBP project. The third edition of this model serves as a guide for frontline
nurses who are striving to improve patient outcomes by translating research into practice.
Evidence-based practice is a way that nurses can continuously improve quality, safety and cost
effectiveness of care received by patients (Dang & Dearholt, 2017).
The JHNEBP model starts with inquiry (Dang & Dearholt, 2017). An individual must want
to learn and determine whether current practice and best practice are equivalent for a specific
patient population or a specific problem. The next step of the model involves the practice
question, evidence, translation (PET) process. There are 19 steps in this process which occurs
within these three phases. The first phase involves generating an interprofessional team,
defining the problem, developing and refining the EBP question, identifying stakeholders,
determining responsibility for project leadership and scheduling team meetings. This could be
considered the planning step. The evidence phase is next, which is comprised of steps seven11. The team must conduct a search for evidence, appraise the level and quality of the pieces of
evidence, summarize the evidence, summarize overall strength and quality of evidence, and
develop recommendations for change based on evidence synthesis. In the last phase,
translation (steps 12-19), the team implements and evaluates the action. More specifically, the
team will determine fit, feasibility, and appropriateness of recommendations, create an action
plan, secure support and resources to implement the action plan, implement the action plan,
evaluate the outcomes, report the outcomes, identify the next steps and disseminate findings.
This process generates best practice, which eventually leads to practice improvements. It is
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important to note that at any time in the process, learning is happening and can lead to inquiry
about another problem or population and the model can be implemented again with the new
topic (Dang & Dearholt, 2017). Figure 1 provides a visualization of the JHNEBP model for
clarity.
Figure 1
JHNEBP Model

Note. The JHNEBP Model was used with permission.
Application of EBP Model to EBP Project
The JHNEBP model was selected for this EBP project due to its detailed nature, which
provides more guidance to the DNP student. The purpose of the JHNEBP model was to serve
as the facilitator to motivate nurses to translate research into practice change which will benefit
patients (Dang & Dearholt, 2017). This coincides with the purpose of this EBP project. The
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spirit of inquiry was initiated because the DNP student was curious about evidence-based
practice, had worked in the particular clinical setting, and was aware of the large number of
patients with GAD. While completing clinical hours there as a student, she wondered if the
current practice for GAD was evidence-based. The EBP project team was created which
included one of the nurse practitioners at the office who served as the site facilitator, the office
manager, and the charge nurse. Stakeholders such as the physician at the office, the other
nurse practitioner, and the medical assistants and nurses were involved and notified of the
project. EBP project team meetings were scheduled. The DNP student was the leader of the
meetings. The purpose of the meetings was to assemble to discuss current practice, review
best practice, and how to implement that at this particular office. Facilitators and barriers were
discussed at these meetings along with logistics of the project. A thorough review of literature
was conducted. The literature was leveled and appraised including evidence from level one to
five and mostly high-quality evidence. A summary was provided of the pieces of literature the
nurses and the providers in the office. The literature was synthesized. Recommendations that a
protocol including education on disease, treatments, and adjunctive therapy, combined with
pharmacological therapy of selective serotonin reuptake inhibitors (SSRIs) and CBT was best
practice was developed based on the evidence synthesis. Finally, this protocol was
implemented in accordance with the action plan. The protocol was evaluated with the site
facilitator to build upon the strengths and limit the barriers of the project to ensure longevity of
this project. Findings were presented to the EBP project team and other staff at the facility.
Findings were also disseminated at the University of Iowa’s EBP conference.
Strengths and Limitations of EBP Model for EBP Project
Strengths of the EBP model include that it provides very detailed steps providing a guide
for the DNP student, making it less overwhelming and more manageable to perform the EBP
process. Using an EBP model can increase the number of nurses willing to participate in EBP
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projects by reducing barriers. These detailed steps follow the nursing process steps of
assessment, plan, implement, and evaluate, which can make the EBP process more
understandable to nurses working in the field. Participating in EBP projects with the assistance
of an EBP model can increase nurse’s involvement making them more satisfied and willing to be
change agents.
Limitations of the model include its complexity with overarching phases with multiple
steps implemented within each phase. In order to be able to use the model to its full capacity, a
thorough review of the model has to be done. Another limitation is the lack of flexibly of this
model. For example, due to the COVID-19 pandemic, the DNP student could not get into the
facility during the first half of the summer in order to do the practice question step of the PET
process. Being in the clinical setting while developing the practice question is ideal because a
clinical problem can be identified with the EBP project team members. Thus, a modified version
of the practice question step was performed and then the DNP student moved on to the
evidence step in order to facilitate progress of the project. The DNP student used her prior
experience at this office to establish that the clinical problem of treatment of GAD could be
addressed. The DNP student cleared this with the EBP team via email due to limitations.
Meetings with the EBP team needed to be postponed until the pandemic was under greater
control, and the DNP student had gotten clearance from the university. Once the DNP student
was allowed to return to the clinical setting, the practice question step was done more
thoroughly, including implementing EBP project team meetings, and assessing current
practices. Modifications to the process are not necessarily explained by Dang and Dearholt
(2017), which brings about concerns that modifications may not be acceptable.
Literature Search
Sources Examined for Relevant Evidence
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An exhaustive literature search was performed to find the most current, relevant
evidence regarding best practice for the treatment of GAD in the family practice setting. A total
of seven databases were searched, along with hand searching and citation chasing. The
databases searched included Joanna Briggs Institute (JBI), Cochrane Library, Trip Database,
MEDLINE with Full Text, CINAHL, PsycINFO, and PsycARTICLES. JBI and Cochrane Library
were utilized because they yield high level evidence of multiple studies such as evidence
summaries, and systematic reviews. CINAHL and MEDLINE with Full Text were chosen for use
due to their ability to produce relevant individual studies such as randomized control trials
(RCTs). Trip Database was searched in order to generate clinical practice guidelines (CPGs),
which are a high level of evidence. PsycINFO and PsycARTICLES were searched to obtain high
level pieces of evidence such as RCTs and because of the psychological nature of the project
topic of GAD.
Inclusion and exclusion criteria were applied to ensure high level, current, relevant, and
applicable evidence was arrived at. Inclusion criteria consisted of scholarly, peer reviewed
sources, provided in the English language, published within the last five years, from 2015-2020,
about GAD. Exclusion criteria included any evidence that pertained to children, any evidence
that included interventions that were not relevant to the family practice setting and evidence that
focused on comorbidities such as cancer or addiction.
The literature search began with JBI. A search using “generalized anxiety disorder*” OR
“anxiety disorder*” with the limiter of 2015- current was used. This search generated 88 results
six of which were accepted for inclusion in the evidence synthesis. All six pieces of evidence
were JBI evidence summaries.
The next database utilized was the Cochrane Library. The keywords “generalized
anxiety disorder*” OR “anxiety disorder*” with the limiter of January 1, 2015- June 1, 2020 was
used. Twenty-two results were obtained. There was one relevant piece of evidence from 2016
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that was found in the literature search. However, this piece of evidence was unavailable and
could not be obtained, and therefore was not used.
The literature search was continued with CINAHL, a search including the key words,
“generalized anxiety disorder*” OR “anxiety disorder*” AND treat* OR intervent* OR manage*
AND “primary health care” OR “primary care” OR “family practice” AND adult* yielded an
appropriate amount of evidence with relevant results. The limiters of scholarly (peer reviewed)
journals, 2015-2020, English language, and research article were applied. Use of these search
terms will be referred to as the “full search”. 78 results were arrived at, of which one RCT was
accepted.
The Trip Database was used next to find CPGs on the topic of GAD. The full search
yielded the best results but had to be modified to accommodate the lack of multiple fields and
was as follows, (“generalized anxiety disorder*” OR “anxiety disorder*”) AND (treat* OR
intervent* OR manage*) AND (“primary health care” OR “primary care” OR “family practice”)
AND adult*. The limiters that were put in place were since 2015 and guidelines. When USA
guidelines was implemented, there were 48 results, none of which were relevant to the EBP
project. Broadening the parameters to guidelines, rather than USA guidelines, generated more
relevant results. Thus, two pieces were accepted to provide supporting evidence for the EBP
project.
The next database that was searched was MEDLINE with Full Text. A slight change
from the full search was implemented. A major heading was utilized of (MH “anxiety disorders”)
and treat* OR intervent* OR manage* AND “primary health care” OR “primary care” OR “family
practice” AND adult* with the limiters of scholarly (peer reviewed) journals, English language
and 2015-2020 and generated 150 results. One piece of evidence was chosen for the evidence
synthesis. This piece of evidence is a preliminary report on a non-randomized control trial.
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Next, the database PsycINFO was investigated. A MESH heading was utilized to limit
results. The following search was conducted, MM “generalized anxiety disorder” AND treat* OR
intervent* OR manage* AND “primary health care” OR “primary care” OR “family practice” AND
adult* with the limiters of scholarly (peer reviewed) journals published from 2015-2020, which
generated 6 results. After reviewing those, one systematic review was chosen to be included in
the evidence synthesis.
Concluding the list of databases, PsycArticles was searched using the full search with
the limiters of scholarly (peer reviewed) journals and 2015-2020. This search produced 7
articles, some of which were duplicates, and none were included for use in the evidence
synthesis. Figure 2 is a PRISMA flow diagram that depicts the literature search and narrowing of
sources.
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Figure 2
PRISMA Flow Diagram

Records identified through
database searching
(n = 377)

Additional records identified
through other sources
(n = 9)

Records after duplicates removed
(n =280)

Records screened
(n = 200)

Records excluded
(n = 150)

Full-text articles assessed
for eligibility
(n =65)

Full-text articles excluded,
with reasons
(n =54)

Studies included in
review
(n = 11)
Note. A figure describing the literature search
Citation chasing was performed in order to find more evidence from the reference lists of
all six pieces of evidence from JBI. Nine current pieces of evidence were obtained from the
reference list of the six JBI studies, none of which were found to be relevant for inclusion in the
evidence synthesis. The JBI studies provided enough clear data and information on the
individual studies, thus the individual studies were not necessary for inclusion.
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A hand search of the American Journal of Psychiatry was conducted of the issues
published in 2020. One relevant piece of evidence was obtained, although it was not chosen for
use in the evidence synthesis because it was a low-level opinion-based editorial with no
scientific base.
There was a total of 377 pieces of evidence obtained during the literature search. These
pieces of evidence were narrowed down initially from a review of their titles and abstracts and
excluded if they were not relevant to GAD in the primary care setting or failed to meet inclusion
or exclusion criteria. Duplicate articles were also removed. After this initial tidying, 65 articles
were extensively reviewed to determine which pieces of evidence were relevant to the EBP
project. After thorough review and evaluation, 11 pieces of evidence were included based on
their strength and applicability to the clinical setting and patient population to support the
particular EBP project.
Levels of Evidence
Melnyk and Fineout-Overholt’s (2015) Hierarchy of Evidence was used to rank the
pieces of evidence by level. In the Hierarchy of Evidence, there are seven levels, with the first
level being the strongest, highest level of evidence, and the seventh being the lowest based on
type of study and how well it was conducted. Level I evidence includes evidence from a
systematic review or meta-analysis of all relevant RCTs. Level II evidence is from well-designed
RCTs. Level III evidence would be defined as obtained from well-designed controlled trials
without randomization. Level IV evidence is from well-designed case-control and cohort studies.
Evidence from systematic reviews of descriptive and qualitative studies is categorized as level V
evidence. Level VI incorporates evidence from a single descriptive or qualitative study. Lastly,
evidence from the opinion of authorities and/or reports of expert committees are considered
level VII evidence (Melnyk and Fineout-Overholt, 2015).
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Out of the 11 pieces of evidence that were chosen for the final literature review there
was a combination of evidence summaries, systematic reviews, CPGs, RCTs, and a preliminary
report on a non-randomized control trial. Six were evidence summaries from JBI, five of which
are level I evidence, and one of which is considered level III evidence. One systematic review
was chosen, which was considered level I evidence from Psych Info. Two CPGs from the Trip
Database were selected for use, both are considered level I evidence. The RCT was found in
CINAHL and is classified as level II evidence. Lastly, a level III preliminary report on a nonrandomized control trial was found in Medline.
Appraisal of Relevant Evidence
After ranking the evidence by level, an appraisal of the quality of each piece of evidence
was conducted. This was performed using the Johns Hopkins Research and Non-Research
Evidence Appraisal Tools. Permission was requested and granted to utilize the Johns Hopkins
Research and Non-Research Tools. The Johns Hopkins Research and Non-Research Evidence
Tools characterize evidence into high quality, good quality, and low quality (Dang & Dearholt,
2017). There are different qualifications for the delineations of high, good and low quality
depending on the type of evidence appraised. Of the 11 pieces of evidence accepted for the
literature review, eight were considered high quality and three were considered good quality. A
summary, leveling and appraisal of the evidence accepted in the synthesis is provided (see
Appendix A).
Level I Evidence
Andrews, Bell, Boyce, Gale, Lampe, Marwat, Rapee and Wilkins (2018). A level I
CPG sponsored by the Royal Australian and New Zealand College of Psychiatrists gives
practitioners a guide to treatment of adults with panic disorder, social anxiety disorder, and
GAD. The CPG provides parameters for diagnosis and assessment strategies.
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This CPG was appraised at a high-level of evidence. There was a clear scope and
purpose. The literature review was thorough. The types of evidence included were systematic
reviews and meta-analyses. The inclusion and exclusion criteria were given. Limitations of the
evidence were given in an honest and unbiased fashion. There was a sufficient amount of welldesigned studies in the literature review. The groups to which the recommendations apply and
do not apply are acknowledged. For example, there are separate sections on treatmentrefractory GAD and GAD in pregnancy. Each recommendation has a leveling system associated
with it and is clear. The guideline was sponsored by a professional organization and was
published within the last 5 years.
Lizarondo (2019). An evidence summary was produced to discuss the evidence
regarding relaxation therapy for patients with GAD. This evidence summary is from a
combination of two systematic reviews and was rated high-quality. The literature search
conducted was thorough and included high-level evidence and although there were not many
systematic reviews, in total 66 RCTs were summarized. This summary is recent as it was
published within the last 5 years and contains systematic reviews from 2018. The
recommendations are clear and do not inflate the evidence from the research.
Jayasekara (2016). An evidence summary that discussed psychotherapy for patients
with GAD was included in the synthesis. There were four Cochrane reviews, a meta-analysis,
four RCTs and an RCT pilot study included in the evidence summary. This evidence summary
was rated a high-quality level. The purpose, clinical question and intended population were
clear. The recommendation was based on research. There was a large number of pieces of
evidence included in the summary from a wide variety of years.
Lizarondo (2020). Another piece of level I evidence addressed exercise for patients
with GAD. This JBI evidence summary was comprised of a systematic review with 12 RCTs and
five meta-analyses, another systematic review of eight RCTs, and two different CPGs. This
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piece of evidence was appraised as high-quality evidence. The author identifies the levels of
each piece of evidence and a grade to the recommendation as well. All of the evidence
summarized was of high-level. The evidence summary was clear and provided unbiased
findings.
Ministry of Health (2015). This level I CPG is a compilation of all the best available
evidence related to anxiety disorders and was appraised as good quality. The material was
officially sponsored by a government agency and results and recommendations were clear with
ratings and leveling provided. Groups to which the evidence applies and does not apply were
clearly delineated. It is stated in the CPG that an extensive review of relevant literature,
including CPGs and expert consensus, was performed, however, no more details were given in
this edition of the guideline about the literature search. This limits the ability to consider this
piece of evidence high quality.
Romano (2019). A JBI evidence summary about self-help was chosen for this literature
review due to its relevance to the EBP project. The evidence summary included four systematic
reviews, five meta-analyses, two RCTs and a Cochrane review. This piece was appraised as
high-quality evidence. The types of evidence included are all high level. The author explicitly
states what patient population the recommendations are geared toward. Each recommendation
has a leveling system attached to it to delineate the strength of the recommendation. All results
reviewed and recommendations are clear and are based on scientific evidence.
Slade (2019). Another JBI evidence summary that is based on nine systematic reviews,
a CPG and a prospective trial was included in the synthesis. This evidence summary discussed
pharmacotherapy for patients with GAD. This piece was appraised as high-quality evidence.
This level I evidence summary included a thorough description of its purpose. The target
population, evidence and recommendations were clearly stated. The sources that were used
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were of high quality and from 2007-2019. There was a clear, brief summary of all results from
the included evidence. The recommendation was clearly linked to a research base.
Slee, Nazareth, Bondaronek, Liu, Cheng and Freemantle (2019). A systematic
review and network meta-analysis was performed to explore pharmacologic treatments of GAD.
89 trails were chosen for the review after a thorough literature review in multiple databases was
conducted. All of these were RCTs. This level I systematic review was appraised as high
quality. A thorough search was conducted using multiple databases. Inclusion and exclusion
were clear. A flow diagram was used to delineate how the studies were selected and which
were eliminated at what level. Limitations to this study are addressed and future
recommendations are made. Specific details about each pharmacologic therapy are included in
clear tables. Results are interpreted and conclusions are clear.
Level II Evidence
Berger, Urech, Krieger, Stolz, Vincent, Moser, Moritz, and Meyer (2017). An RCT
was conducted to investigate whether transdiagnostic, unguided internet cognitive behavioral
treatment (ICBT) for anxiety disorders is more effective in primary care settings than care as
usual. This piece of evidence was deemed good quality level of evidence. The purpose of the
study was articulated well. The sample size was small with 139 subjects, considering the
researchers aim was to obtain 176 subjects, but they were still able to have sufficient power
(>0.80). A thorough literature review was performed, and recommendations are based on that
as well as the researchers own results. There were no statistically significant differences
between the control group and the experimental group on demographic characteristics or other
variables. The researchers reported some limitations including the fact that generalizability is
limited given that Velibra was a very specific intervention. The lack of generalizable results was
the reason that this piece of evidence did not receive a high-quality rating. The control group
was given access to the intervention at the end of the study period, increasing the studies
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ethical strength.
Level III Evidence
Lizarondo (2018). An evidence summary written by Lizarondo (2018) discussed
smartphone-based interventions as best practice to treat GAD. The subject matter that was
reviewed was clearly stated. The literature review was done using a structured search and
included mostly high-level evidence. The literature was relevant and within the last five years.
There was a clear conclusion drawn from the evidence reviewed with rationales. The
recommendation was determined to be grade B. This piece of evidence only reviewed three
pieces of evidence, one of which was a systematic review of nine studies. This could limit its
strength. However, smartphone-interventions are a new topic, therefore research already
conducted and published may be limited. Thus, this piece of evidence was given a rating of
high quality.
Level V Evidence
Yu, Szigethy, Wallace, Solano and Oser (2018). This piece of evidence is a
preliminary report on a non-randomized control trial. This piece of evidence was appraised as
good quality. The purpose of the study is clearly presented. The intervention was clearly stated.
There was a high rate of loss of participants, which limits the strength of this study. Originally,
593 individuals consented to participate in the study, but only 310 actually installed the appbased intervention called Lantern. Further, only 63 of those completed both baseline and twomonth GAD-7 measurements. The outcome measures were clear, the GAD-7 had a Cronbach
alpha > 0.70. The results are clear and have clinical significance. Tables are used to increase
clarity. A disclosure notice of potential bias is given.
Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
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The literature indicated consistent results and recommendations for best practice for the
treatment of GAD. The included evidence overall is strong consisting mostly of level I highquality evidence. Common themes were generated from these consistent results. The evidence
indicated that treatment of adults with GAD should include (a) education about disease etiology
and lifestyle factors such as relaxation techniques and exercise, (b) CBT administered in the
form of a smartphone app, and (c) SSRI pharmacotherapy.
Population
The literature reviewed mainly addressed adults aged 18 and over (Andrews et al.,
2018; Berger et al., 2017; Ministry of Health, 2015; Romano, 2019; Slade, 2019; Slee, 2019; Yu
et al., 2018). Pediatric GAD treatment is complex making the primary care setting potentially
inappropriate (Andrews et al., 2018; Ministry of Health, 2015). Adult patients should be
diagnosed with GAD by a provider using the DSM V criteria (Andrews et. Al., 2018). This criteria
for diagnosis of GAD includes a) excessive anxiety and worry about multiple events or activities
must be present for a majority of days throughout a time period of at least 6 months, b) the
worry is difficult to control, c) the anxiety and worry are associated with three or more of the
following six symptoms in adults or one or more of the following six symptoms in children:
1. feeling restless or on edge
2. easily fatigued
3. difficulty concentrating or remembering thoughts
4. irritability
5. muscle tension
6. sleep disturbance (trouble falling or staying asleep, restlessness during sleep,
feeling unsatisfied with sleep)
d) significant impairment in functioning, social, and/or occupational aspects, e) the anxiety,
worry, and symptoms are not associated with the use of a substance (drug abuse or medication
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use) nor another medical condition, f) there is a lack of a better explanation for such difficulty
including another medical disorder, mental disorder, or anxiety disorder (American Psychiatric
Association, 2013). Patients with suicidal ideations, psychosis, substance use disorders or
personality disorders are often excluded due to the complexity, and providers are typically
directed to refer these patients to psychiatry (Andrews et al., 2018; Berger et al., 2017; Ministry
of Health, 2015; Yu et al., 2018). The patients were under outpatient management, rather than
in inpatient settings, as again, this is something that is beyond the scope of a primary care
provider.
Interventions
Education. The literature clearly states that patients with GAD should be educated
about their disease process, treatments, relaxation techniques and lifestyle modifications
(Andrews et al., 2018; Berger et al., 2017; Lizarondo, 2019; Lizarondo, 2020, Ministry of Health,
2015; Yu et al., 2018). Although it is not stated precisely how this education should be
implemented, it is clear that it should be provided. Options for modes of education include
verbal communication, written handouts, during beginning portions of CBT or in a combination
of these (Andrews et al., 2018; Berger et al., 2017; Yue et al., 2018). This information should be
from reliable sources and provided in a way that is understandable to the patient, including in
their language of choice, and at a level the patient can understand without difficulty (Andrews et
al., 2018). The CPG by Ministry of Health (2015) recommends that education include the cause
of GAD, prognosis, and that GAD is a common disorder experienced by many (Ministry of
Health, 2015).
Decisions about treatment should be made using shared decision making, which
incorporates the provider’s expertise, the patient’s preferences and the best practice evidence
(Slade, 2019). In order for patients to be able to make a decision regarding treatment of GAD,
they must be informed about all options for treatment. Information that should be incorporated
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includes but is not limited to, treatment description, cost, adverse effects, length of treatment
and importance of consistent use (Andrews et al., 2018; Ministry of Health, 2015).
Information about relaxation techniques should be provided as part of the education
(Andrews et al., 2018; Lizarondo, 2019; Ministry of Health, 2015). Primary care providers and
nurses can be trained to educate patients about relaxation techniques including breathing
control, meditation and progressive muscle relaxation (Ministry of Health, 2015). These
therapies can be an easy, inexpensive, and effective method to reduce anxiety symptoms and
improve quality of life (Andrews et al., 2018; Lizarondo, 2019). One systematic review found that
relaxation techniques were as effective as CBT for treatment of GAD (Lizarondo, 2019).
Lifestyle modifications can not only improve the symptoms of anxiety but can also
improve overall health and wellbeing for patients with GAD (Lizarondo, 2020). Exercise has
been shown to be effective in improving anxiety symptoms, reducing physical symptoms and
improving quality of life (Lizarondo, 2020; Andrews et al., 2018). While there are no specific
recommendations for exercise, encouraging patients to perform aerobic, non-aerobic and/or
resistance training can be of benefit (Lizarondo, 2020; Ministry of Health, 2015). Other self-care
methods such as healthy eating, adequate sleep, and reduction of caffeine, tobacco, drugs and
alcohol can also reduce anxiety symptoms (Ministry of Health, 2015; Andrews et al., 2018). In
mild cases of GAD, education along with relaxation techniques and lifestyle factors may be
enough to effectively treat symptoms, with minimal to no adverse effects, and minimal health
care costs (Andrews et al., 2018).
CBT. There is a consensus that CBT is the most effective psychological intervention for
reducing anxiety symptoms, backed by an astonishing amount of high quality, high level
evidence (Andrews et al., 2018; Berger et al., 2017; Jayasekara, 2016; Lizarondo, 2018;
Ministry of Health, 2015; Romano, 2019; Yu et al., 2018). Not only can CBT be used to improve
symptoms, but it can help maintain remission and prevent relapse of GAD (Jayasekara, 2016).
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There is much support for the effectiveness of face-to-face CBT administered by a licensed
professional (Andrews et al., 2018; Jayasekara, 2016; Ministry of Health, 2015; Yu et al., 2018).
However, there are many barriers to face-to-face CBT in both psychiatric and primary care
settings including high cost, lack of providers, lack of experience in facilitating CBT, lack of
facilities, high time commitment and lack of transportation to the facility (Lizarondo, 2018;
Romano, 2019). To combat these barriers, CBT can be conducted through the use of
smartphone apps or internet programs. Digital CBT has been shown in some studies to reduce
anxiety symptoms, maintain symptom reduction and achieve remission more than waitlist and
placebo controls and as effectively as face-to face CBT (Romano, 2019; Yu et al., 2018;
Lizarondo, 2018; Andrews et al., 2018). Digital CBT has not only been shown to be effective but
has also been shown to increase accessibility to CBT, increase fidelity, decrease costs for the
patient and the health system, and be as safe as other methods of CBT (Andrews et al., 2018).
There are various programs available that have shown success for treatment of CBT (Yu et al.,
2018; Berger et al., 2017). Berger et al. (2017) examined the use of a digital CBT program
called Vellibra, where 70 participants were treated with care as usual plus Vellibra and 69
participants were treated with care as usual. Vellibra is an internet intervention that consists of
six modules focused on CBT. In this study, there was a significant decrease in Penn State Work
Questionnaire (PSWQ) scores from 62.7 (SD = 9.3) pre-treatment to 58.4 (SD = 11.1) posttreatment (p < 0.05). At the completion of this study, 44.8% of patients who had GAD no longer
met criteria for diagnosis (Berger et al., 2017). Another study by Yu et al. 2018, demonstrated
the effectiveness of digital CBT by providing Lantern, a smartphone CBT app to the
experimental group. There was a statistically significant decrease in GAD-7 scores from preintervention (11.5) to post intervention (9.4) (p = 0.009) (Yu et al., 2018). Patients should be
given instructions on how to use the chosen program and they should work through the program
for at least six weeks (Romano, 2019). The more patient engagement in a program, the better
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the outcomes tend to be (Yu et al., 2018). For example, in one study by Yu et al. (2018),
participants who completed three or more units showed a statistically significant GAD-7
reduction as compared with those who completed less than three units. There are minimal
adverse effects associated with CBT, increasing its acceptability and strength (Andrews et al.,
2018; Yu et al., 2018). A side effect of CBT includes emotional distress brought upon by
reviewing traumatic experiences. However, CBT usually produces no serious adverse effects
(Andrews et al., 2018).
Pharmacotherapy. The literature also supported use of pharmacotherapy, typically
SSRIs for the treatment of GAD (Andrews et al., 2018; Ministry of Health, 2015; Slee et al.,
2019; Slade, 2019). SSRIs were found to be more efficacious for treatment of anxiety symptoms
compared to placebo (Slade, 2019). While the evidence is clear that SSRIs have the most
evidence supporting that they are effective and tolerable for the treatment of GAD, there is
conflicting evidence about which SSRI is best. Slade (2019) reported that one review indicated
that fluoxetine was most effective, whereas sertraline was most tolerable. However, Slee (2019)
after comparing 22 different pharmacologic therapies indicated that escitalopram was found to
be the most efficacious and tolerable. According to Slee (2019), sertraline and fluoxetine were
also effective and well tolerated, but recommendations were limited due to a smaller sample
size. Slee (2019) found that paroxetine was effective but not well tolerated. Some side effects
that can occur with SSRIs include nausea, dry mouth, constipation, and drowsiness, which
occur more often than with placebos (Ministry of Health, 2015). Benzodiazepines, while
effective, are not recommended as first line for the treatment of GAD due to the risk of adverse
effects, tolerance, dependence and abuse (Andrews et al., 2018; Ministry of Health, 2015; Slee
et al., 2019; Slade, 2019). Propranolol has not been shown to have efficacy in the treatment of
GAD (Andrews et al., 2018; Ministry of Health, 2015; Slade, 2019). In review, an SSRI should
be chosen with clinical judgment and patient preferences in mind (Slade, 2019).
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Combination of SSRI and CBT There was support for the combination of CBT and
SSRIs in all patients, but especially in patients with severe disease (Andrews et al., 2018;
Slade, 2019; Slee et al., 2019). Severe disease can be defined as a score of 15-21 on the GAD7 or patients who report extreme distress or functional impairment such as inability to perform a
daily role more than seven days per month (Andrews et al., 2018). Combination therapy for a
patient already on SSRI therapy can facilitate remission of anxiety and allow weaning from SSRI
in order to inhibit long-term pharmacotherapy (Slade, 2019). There was reluctance from some
organizations to recommend a combination of face-to-face CBT and pharmacotherapy due to
cost, but with digital CBT, cost as a barrier is eliminated or reduced (Ministry of Health, 2015).
Evaluation
Evaluation is an important part of care to ensure the intervention is effective and the
patient is improving. During therapy, patients should be evaluated weekly to ensure compliance,
adverse effects, and to assess for deterioration of symptoms (Andrews et al., 2018). Typically,
medication and CBT start to have some efficacy between 4-6 weeks after initiation, so patients
should be assessed using an approved measurement tool at that time (Andrews et al., 2018;
Slade, 2019). After the 4-6-week time period, depending on response to initial treatment,
adjustments can be made to treatment (Andrews et al., 2018). Slade (2019) suggests that if
pharmacologic therapy is not showing any efficacy at 4 weeks, it is unlikely that more time will
promote further efficacy.
Outcomes
Many different outcomes measured with many different measurement tools were used
among the literature in the literature review. Outcomes included reduction in anxiety symptoms,
relapse rate, dropout rate, side effect, quality of life, cost-effectiveness, feasibility, remission
rates, tolerability, and engagement. The most commonly used tools were the GAD-7 (Andrews
et al., 2018; Ministry of Health, 2015; Yu et al., 2018) , PSWQ-3 (Andrews et al., 2018; Berger et

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

26

al., 2017), HAM-A (Slee et al., 2019) and the Clinical Global Impression Scale (Ministry of
Health, 2015). The GAD-7 is a 7-item screening tool for GAD that can be used to measure the
severity of anxiety symptoms. The scores range from 0-21. A score of 10 or greater is
suggestive of GAD (Andrews et al., 2018). It is recommended that because of the high rates of
comorbidity, a patient suspected to have GAD should also be screened for depression
(Andrews et al., 2018). PHQ-9 can be used to screen for depression. This is a 9-item screening
tool. In terms of timing of evaluation, most studies used outcomes measurement at preintervention and post-intervention (Andrews et al., 2018; Berger et al., 2017; Ministry of Health,
2015; Yu et al., 2018); one study measured outcomes weekly (Andrews et al., 2018).
Best Practice Model Recommendation
The reviewed literature indicated the current best practice for the treatment of GAD in adults in
the primary care setting includes combination therapy that includes education, CBT and
pharmacotherapy. The education addressed disease etiology, disease treatments, and lifestyle
factors such as relaxation techniques and exercise. This education was provided in a written
handout that was reviewed verbally by the DNP student (see Appendix B). Education about
pharmacotherapy was provided verbally by the provider as well. This information was also
summarized in the handout given to them. CBT was administered via smartphone app. The
particular app that was selected for use is called MindShift. This app is free of charge. The app
is only provided in English. The user must create a username and password to log in. This app
was created in Canada with support from organizations including Anxiety Disorders Association
of British Columbia, Kelty Mental Health Resource Centre and Mental Health and Substance
Use Services. This app is designed to help people cope with stress and anxiety and provides
education about GAD and CBT as well as self-care and resources such as a thought journal,
coping cards and belief experiments. The app also includes relaxation exercises that the patient
can perform. Through the app, the patient can also set goals. One example of a goal is lifestyle
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changes such as walking 30 minutes in the morning three times a week. MindShift was chosen
after a preliminary search and review of apps for anxiety disorder. This app is free of charge and
did not include in app purchases. It is backed by medical organizations, such as Mayo Clinic. It
is user friendly. The app facilitates CBT rather than just meditation or mindfulness. Lastly, best
practice for pharmacotherapy is initiating treatment with an SSRI. In order to promote ease of
pharmacologic therapy initiation and titration, a guide was given to the providers in the office
that reviewed starting, target and maximum doses for SSRIs, common adverse effects, and
contraindications (see Appendix C). A clinical decision tool was given to the providers in the
office to help decision making when it comes to responses at the 4-6-week mark, and when to
refer patients (see Appendix D). This information aimed to increase provider confidence in
prescribing these medications.
In conclusion, a protocol consisting of a combination of education via written and oral
methods, CBT via smartphone-app MindShift and pharmacology of SSRI therapy was initiated.
This protocol was a combination of the best evidence found in the literature to treat patients with
GAD.
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
The evidence led the DNP student to create a protocol that included education, CBT via
smartphone app and SSRI pharmacotherapy. The goal of the protocol was to improve
symptoms and quality of life for patients with GAD. On a larger scale, consistent evidencebased treatment across the nation could decrease the number of patients on controlled
substances such as benzodiazepines, decrease suicide rates, and standardize care for these
patients. Education was provided to the patient via verbal and written modalities. This protocol
also included education for the providers about prescribing SSRIs, best practice
recommendations for GAD and when they should seek referral for the patient to psychiatry. CBT
was conducted via smartphone app. This particular mode of implementation was an attempt to
increase access and decrease costs of a specialized treatment. An SSRI prescription was given
to patients if not contraindicated.
Participants and Setting
This EBP project took place at a rural family practice office in northeast Indiana that
provides primary care services to patients from birth to death. There is one physician who is the
collaborating physician for the two nurse practitioners in the practice. One nurse practitioner,
who was also the site facilitator has been practicing as a nurse practitioner for 46 years. The
other nurse practitioner has been practicing for eight years.
Patients who were eligible for the EBP project include adult patients 18 years of age or
older, who have been previously or presently diagnosed with GAD as confirmed by the DSM-5
criteria. The patients had to be able to speak and understand spoken and written English.
Patients who were pregnant, had current suicidal or homicidal ideations, active psychosis,
and/or concurrent alcohol or drug abuse were excluded from the EBP project, as it would be
more appropriate for a psychiatrist to be managing these severe cases. These patients were
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referred to a psychiatrist as indicated in the clinical decision tool created for providers. Patients
on other psychiatric medications such as benzodiazepines or serotonin norepinephrine reuptake
inhibitors (SNRIs) were not excluded as this would have greatly reduced sample size and it
would be unethical to cease current anxiety medications. If an SSRI was not contraindicated
with current pharmacotherapy, such as in a patient who is prescribed a benzodiazepine, a
prescription was provided to the patient. Patients on therapy such as an SNRI where adding an
SSRI was not safe, were included in the project as these patients may benefit from the addition
of CBT and education.
The DNP student had a list of patients in the practice who have been diagnosed with
GAD. This information was provided by the office manager who ran a report on all of the
patients who were diagnosed and/or treated with GAD from January 2018- September 2020. A
chart review was performed by the DNP student to determine whether patients were eligible.
The DNP student had access to patients’ electronic medical record and performed a search to
determine which pharmacologic therapy the patients were already on and whether or not
inclusion and exclusion criteria were met. This was conducted before the patients were recruited
to be in the project. The patients were recruited during their usual clinic appointments, either
initial or follow up.
Pre-Intervention Group Characteristics
All participants were aged 18 and older. Participants were asked to complete a form with
demographic information on it to be used at their initial visit after agreeing to be in the EBP
project (see Appendix E). This form helped to gain information about the patient. Data was
collected at pre-intervention and post-intervention to determine whether any changes were
made during implementation.
Intervention
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A significant amount of time was spent to plan this EBP project with a foundation in the
literature. The evidence base pointed to a combination of education, CBT and SSRI
pharmacotherapy. After meeting with the stakeholders, it was decided that many patients in the
practice lack access to CBT and financial resources to have the ability to enroll in face-to-face
CBT. Therefore, because there was support in the literature for the effectiveness of digital CBT
and smartphone app guided CBT, a decision was made to seek out digital self-guided CBT that
could be used at the patient’s convenience or at times of exacerbations. An educational handout
was created using suggestions from the providers and from the literature. Input for the
educational handout was received from the site facilitator and the other nurse practitioner in the
practice in coordination with the literature.
The intervention consisted of development of a protocol based on best practice
recommendations from the evidence chosen for the synthesis. This protocol included treatment
with education, CBT via smartphone app and SSRI pharmacotherapy. It was recommended that
shared decision making with the provider, patient and family members should occur (Andrews et
al., 2018). Each participant verbally consented to participate in the project. A clinical decision
tool was provided to the providers that could be used as a guideline to direct them in their
interventions and referrals (see Appendix D). The education consisted of information about
CBT, SSRIs, exercise, relaxation techniques, dietary changes, essential oil use, smoking
cessation and reduction of alcohol intake. The patient was given oral as well as written
information in order to further facilitate learning (see Appendix B). They were also provided
information about the CBT smartphone app called MindShift. There was a handout that included
screenshots of the steps that the patient will take to obtain the MindShift app (see Appendix F).
They were educated that they should utilize the app during exacerbations of their anxiety and at
least once weekly up to as often as they would like (Andrews et al., 2018). This education was
provided by the DNP student. The nurses and medical assistants were trained on how to
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perform this education for the sustainability of the project and protocol after it is completed. This
training for the nurses and medical assistants was about 30 minutes long and was conducted by
the DNP student. They were asked to record when and for how long they used this app on a
time sheet log (see Appendix G). They also were asked to record when and for how long they
exercised and used relaxation techniques on the time sheet log. Participants were provided with
a prescription for an SSRI, as long as it was not contraindicated. The provider was given an
educational handout about SSRIs including dosing, side effects and caveats with prescribing.
The patient was instructed to fill the prescription at a pharmacy of their choice and educated on
how to take their medication, including dose and frequency. They were advised to take this
medication as directed and contact the health care provider if they had any concerns or want to
discontinue the medication. They were provided education about the SSRI such as side effects,
mechanism of action, duration of use, and timing of therapeutic effect.
Comparison
There are many challenges when it comes to treating GAD. There is stigma associated
with mental illness which can deter patients from seeking help for these problems. If they do
seek help, sometimes they are focused on the somatic issues that come along with GAD, and
the provider can miss the psychiatric cause behind these somatic complaints (Andrews et al.,
2018). There is a lack of psychiatrists and providers that can facilitate CBT, which decreases
access and can increase costs for patients. Lack of knowledge or patient preference can hinder
prescribers from prescribing first line pharmacologic therapy for patients. Time can be an
impediment to the amount of education is given to the patient. This EBP project aimed to
decrease these challenges and improve treatment of GAD.
There were 800 patients with GAD in the practice during the implementation period of
the project. Education given to patients before implementation of the EBP project varied based
upon provider and patient. For example, one nurse practitioner commonly talked to patients

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

32

about relaxation techniques for patients with GAD, while the other typically did not discuss
relaxation techniques.
Outcomes
Multiple outcomes were selected for measurement as identified in the literature. The
primary outcomes measured are anxiety level based on the GAD-7 scale (see Appendix H), and
depression symptoms based on the PHQ-9 (see Appendix I). The GAD-7 is a 7-item self-report
scale used to measure symptom severity experienced by the patient in the last 2 weeks. Total
scores on the GAD-7 of 0-4 indicate no or minimal anxiety, 5-9 indicate mild anxiety, 10-14
indicate moderate anxiety, 15-21 indicate severe anxiety. The GAD-7 has good internal
consistency indicated by a Cronbach’s alpha of 0.92 (Yu et al., 2018). The PHQ-9 is a 9-item
self-report scale used to measure depressive symptoms experienced by the patient in the last 2
weeks. Both scales use a Likert scale from 0-3 to rate the questions from 0 “not at all” to 1
“several days”, 2 “more than half the days” and 3 “nearly every day”. This is in accordance with
the literature in that many times anxiety and depression occur concurrently, and it would be a
disservice to the patient if one went undetected (Andrews et al., 2018). Secondary outcomes
include time spent exercising, time spent performing CBT via app, time spent doing relaxation
techniques, usage of a benzodiazepine, and number of patients prescribed an SSRI.
Before the intervention was implemented, the patients’ GAD-7 and PHQ-9 was
assessed. The patients’ baseline exercise, CBT, relaxation technique habits, and
benzodiazepine use were assessed using a patient questionnaire (see Appendix J). These
baseline data were used to compare to the data that were collected again at 4 weeks, 8 weeks
and 12 weeks. This data were collected either by phone or in person depending on timing of
patient appointments. The data were compared to determine whether GAD and depressive
symptoms had improved, and how much the patient utilized relaxation techniques, exercise, the
CBT app and benzodiazepines to combat symptoms.
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The data were analyzed using one-way repeated measures analysis of variance
(ANOVA) because there was one group receiving the intervention and the level of measurement
of the variables was interval/ratio. This data analysis method was also chosen because there
were four points in time that the data were collected. This will also show at what point in
treatment a significant change occurred. The data were broken down by all 7 questions in the
GAD-7 and all 9 questions in the PHQ-9 in order to determine whether a certain aspect of the
patient’s symptoms improved, as well as the total score for both scales.
Time
Implementation of the project took place starting in August 2020 with the beginning of
the school semester, once planning and education of providers and staff had occurred.
Education was conducted by the DNP student, on the first week of the semester during the
staff’s morning huddle. The staff was provided copies of the educational information that were to
be given out to participants, and information about their role in the project including what
education they will be providing once the DNP student left. The DNP student began recruiting
patients to be involved in the EBP project based on their eligibility for the project. Once the
patient agreed to be involved, data collection began, and the intervention started.
Protection of Human Subjects
Protection of human subjects was a priority throughout the project. The DNP student
completed education about protection of human subjects through the DNP curriculum and by
completing an online training course through the Collaborative Institutional Training Initiative
(CITI) on April 1, 2020. The DNP student applied for approval for the project by Valparaiso
University’s IRB. The DNP student was granted exemption from review on July 18, 2020.
Participation in the project was voluntary. The patient’s confidentiality was upheld. The patients
did not receive any reward for participating in the project. Patients who chose not to participate
were given the same education and information about obtaining the CBT app. Providers were
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encouraged to prescribe SSRIs for the patients with GAD who chose not to participate in the
project. Patients were able to withdraw from the project at any time without retribution. Data was
kept in a secure, locked laptop and paper documents were kept in a locked cabinet. There were
no names kept on documents as number codes were given to patients in order to uphold
anonymity.
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CHAPTER 4
FINDINGS
The purpose of this EBP project was to see if implementing a protocol involving
combination therapy with CBT, SSRI, and education would decrease anxiety and depression
symptoms for patients. Anxiety symptoms were measured via the GAD-7 scale. Depression
symptoms were measured via the PHQ-9 scale. These were measured at baseline and then
again at four, six and 12 weeks post intervention. Secondary outcomes that were measured
included amount of time exercise was performed, amount of time spent on app performing CBT
app, amount of time spent doing relaxation techniques, usage of a benzodiazepine, and number
of patients prescribed an SSRI.
Participants
A total of 24 individuals agreed to participate in the EBP project. They all completed the
demographic form, patient questionnaire, PHQ-9 and GAD-7 scales for baseline data and
agreed to follow up for a total of 12 weeks with three additional appointments either by phone or
in person. At completion of the project, 14 participants had completed follow up with a total of
four encounters. This yields a final attrition rate of 41.7%.
Participants demographic characteristics were analyzed. The average age of the
participants was 46.5833 (SD = 15.33656). There were more females (87.5%) than males
(12.5%) who participated (See Figure 1). All of the participants had at least a high school
diploma or GED, while 20.9% of participants obtained a college degree (Figure 2). The majority
of the participants were Caucasian (91.7%). Black individuals made up 4.2% of the population
(Figure 3). The majority of the participants had private insurance (54.2%) (Figure 4). Half of the
participants were married (See Figure 5). The annual gross household income level that was
most commonly reported was less than $20,000 (25%) (Figure 6). Half of the participants were
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employed full-time outside the home (Figure 7). Descriptive statistics of the demographic data
are presented in Table 1.
Participants were given a prescription for an SSRI if one was not contraindicated such
as in the case of a concomitant SNRI usage, allergy or adverse reaction. Of the 24 participants,
three were prescribed citalopram (Celexa), one was prescribed paroxetine (Paxil), four were
prescribed escitalopram (Lexapro) and three were prescribed sertraline (Zoloft). 11 other
participants were already on SSRIs at baseline. If the dose previously prescribed was not at
therapeutic dose, the dose was increased to the therapeutic dose at baseline. At the start of this
project 11 out of 24 (45.8%) of the participants were prescribed an SSRI. 11 more were
prescribed an SSRI during this project implementation. Therefore 91.6% of participants were on
SSRI therapy at the end of this project. Participants who were on an SNRI or other medication
were offered CBT and education to add to their pharmacologic therapy. One participant refused
to be started on an SSRI, although did not refuse CBT and education.
There were 10 participants who did not complete the project until completion. Most
(80%) did not follow up after initial intervention. The average age of these participants was 45
(SD = 16.67333). Two-thirds of the males originally recruited did not complete the project until
it’s end.
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Table 1
Demographic Characteristics
____________________________________________________________________________
Demographic

Frequency (%)

____________________________________________________________________________
Number of participants at commencement

24 (100%)

Number of participants at completion

14 (58.3%)

Attrition

10 (41.7%)

Age
Mean/SD

46.5833/15.33656

Range

18-72

Male

3 (12.5%)

Female

21 (87.5%)

Other

0 (0%)

Sex

Education
Less than high school

0 (0%)

High school/GED

9 (37.5%)

Some college with no degree

10 (41.7%)

2-year college degree (Associates)

1 (4.2)

4-year college degree (Bachelors)

3 (12.5%)

Master’s degree

1 (4.2%)

Doctoral degree

0 (0%)

African American

1 (4.2%)

Race
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Asian-Pacific Islander

0 (0%)

Caucasian

22 (91.7%)

Hispanic

0 (0%)

Native American

0 (0%)

Other

0 (0%)

Prefer not to answer

1 (4.2%)

Health Insurance
No insurance

1 (4.2%)

Medicare

6 (25%)

Medicaid

4 (16.7%)

Private insurance

13 (54.2%)

Marital Status
Single

5 (20.8%)

Married

12 (50%)

Separated

0 (0%)

Divorced

7 (29.2%)

Widowed

0 (0%)

Income
Less than $20,000

6 (25%)

$20,000-$34,999

3 (12.5%)

$35,000-$49,999

4 (16.7%)

$50,000- $74,999

4 (16.7%)

$75,000- $99,000

4 (16.7%)

$100,000 or more

1 (4.2%)

Employment
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Employed full time

12 (50%)

Employed part time

0 (0%)

Unemployed and currently looking for work

2 (8.3%)

Unemployed and not currently looking for work

1 (4.2%)

Student

1 (4.2%)

Retired

2 (8.3%)

Homemaker

0 (0%)

Self-employed

2 (8.3%)

Unable to work/disabled

3 (12.5%)

Prefer not to answer

1 (4.2%)

Figure 3
Demographic Information: Sex

Note. There were more females than males in the population.
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Demographic Information: Education Level

Note. All of the participants had at least a high school diploma/GED
Figure 5
Demographic Information: Race
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Note. Most participants were Caucasian.
Figure 6
Demographic Information: Health Insurance

Note. Most participants had private insurance.
Figure 7
Demographic Information: Marital Status
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Note. Most participants were married.
Figure 8
Demographic Information: Annual Gross Household Income

Note. Most participants made less than $20,000 per year.
Figure 9
Demographic Information: Current Employment Status
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Note. Half of the participants were employed full time.
Changes in Outcomes
The PICOT question that was addressed by this EBP project was: Among adult patients
presenting with generalized anxiety disorder (GAD) in the primary care setting (P), does the
introduction of a protocol consisting of treatment with education via a written handout, a
selective serotonin reuptake inhibitor (SSRI) and digital cognitive behavioral therapy (CBT) via
smartphone application (app) (I) compared to current practice of no protocol (C), improve GAD
symptoms as measured by patient-reported scores on the Generalized Anxiety Disorder 7-item
(GAD-7) scale and Patient Health Questionnaire 9-item (PHQ-9) scale (O) over a 12-week
period (T)? Therefore, the primary outcomes were anxiety and depression symptoms measured
via the GAD-7 scale and the PHQ-9 scale, respectively. Secondary outcomes included total
time of exercise, relaxation techniques, and CBT via application per week, amount of
benzodiazepine use, and amount of SSRI prescriptions.
Statistical Testing and Significance
Statistical Package for Social Sciences (SPSS) was the system utilized for data analysis.
Cronk (2019) was used as a guide for data analysis and interpretation. A one-way repeated
measures ANOVA was used to analyze the data from participants’ PHQ-9 and GAD-7 scores
because these were measured within one group at four difference times. Exercise, relaxation
and CBT times, benzodiazepine usage and SSRI prescription amounts were analyzed by
performing pair-samples t-tests because these were measured at pre-intervention and at the 12week measurement.
Findings
Primary Outcomes
Anxiety Symptoms. Anxiety symptoms were scored using the GAD-7, which has seven
questions asked in a Likert scale format (See Appendix H). The overall prompt is “over the last
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two weeks how often have you been bothered by any of the following problems?” and then the
seven questions address symptoms of anxiety. The Likert scale consists of either not at all
(zero), several days (one), more than half the days (two), and nearly every day (three). The
score is totaled for all seven questions and can range from zero-21. Higher scores indicate
higher levels of anxiety symptoms. A one-way repeated measures ANOVA was calculated
comparing the total scores of participants at four different times: at baseline, week four, week
eight, and week 12. A significant effect was found (F (3,39) = 6.992, p < .001). Follow up
protected t tests revealed that scores decreased significantly from baseline (M = 12.5714, SD =
6.51288) to week 8 (M = 5.2857, SD = 4.26846) and from baseline to week 12 (M = 6.1429, SD
= 5.88162). During patient follow ups, there were anecdotal comments that were made that can
provide evidence of clinical significance. One participant said on her week 4 follow up visit, “I
haven’t felt this good, ever. I noticed a huge difference just since my last visit. I never want this
medication [SSRI] taken away from me”. Many participants reported that they were thankful that
the DNP student was there in their time of need.
Depression Symptoms. Depression symptoms were measured using the PHQ-9, which
has 9 different questions asked in a Likert scale format (See Appendix I). The overall prompt is
“over the past two weeks how often have you been bothered by any of the following problems?”
and then the nine questions proceed to ask about symptoms of depression. The responses are
the same as GAD-7 and are as follows: not at all (zero), several days (one), more than half the
days (two), and nearly every day (three). The score is then totaled for all nine questions with
higher scores indicating higher levels of depression symptoms. The scores range from 9-27. A
one-way repeated measures ANOVA was calculated comparing the total scores of participants
at four different times: at baseline, week four, week eight, and week 12. A significant effect was
found (F (3, 39) = 8.867, p < .000). Follow up protected t tests revealed that scores decreased
significantly from baseline (M = 12.4286, SD = 7.70329) to week eight (M = 4.7143, SD =
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4.51372) and from baseline to week 12 (M = 4.6429, SD = 5.25660) (See Table 3). To
demonstrate clinical significance, one participant stated during a follow up visit, “I was never
suicidal, but I would keep my leftover pills, and saved enough up that if I ever needed to or if
things ever got bad enough, I would have enough ammo to do it. I recently just took all those
leftover pills to the pharmacy because I know now that I will never need them.” Table 2 depicts
one-way repeated measure ANOVA results with means and standard deviations for the primary
outcomes of anxiety and depression symptoms.
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Table 2
One-Way Repeated Measure ANOVAs with Means and Standard Deviations for Primary
Outcomes
Variable

Mean

SD

F

p

Baseline

12.5414

6.51288

6.992

.001*

Week 4

9.2143

6.47098

Week 8

5.2857

4.26846

Week 12

6.1429

5.88162

Baseline

12.4286

7.70329

8.867

.000*

Week 4

8.9286

6.17020

Week 8

4.7143

4.51372

Week 12

4.6429

5.25660

Anxiety
Symptoms

Depression
Symptoms

Note. * signifies clinical significance
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Table 3
Follow Up Protected T-tests
Variable

Mean
Difference

SD

t

df

p

Baseline to
Week 4

3.3571

7.20691

1.743

13

.105

Baseline to
Week 8

7.28571

6.89959

3.951

13

.002

Baseline to
Week 12

6.42857

7.29293

3.298

13

.006

Week 4 to
Week 8

3.92857

6.55702

2.242

13

.043

Week 4 to
Week 12

3.07143

7.11947

1.614

13

.130

Week 8 to
Week 12

-.85714

4.05457

-.791

13

.443

Baseline to
Week 4

3.50000

7.57272

1.729

13

.107

Baseline to
Week 8

7.71429

7.89770

3.655

13

.003

Baseline to
Week 12

7.78571

7.37124

3.952

13

.002

Week 4 to
Week 8

4.21429

6.45909

2.411

13

.030

Week 4 to
Week 12

4.28571

6.28097

2.553

13

.024

Week 8 to
Week 12

.07143

3.29252

.081

13

.937

Anxiety
Symptoms

Depression
Symptoms

Secondary Outcome

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

48

Exercise Usage. Participants were educated about use of exercise to improve GAD
symptoms and overall health as part of the protocol. Exercise data were collected via patient
report on the patient questionnaire that was administered at baseline and at week 12. They
answered whether they exercised or not via a yes or no question. If they answered yes,
participants were prompted to answer what type of exercise they did, how many times per week,
for how many minutes, and whether the exercise was mild, moderate or strenuous. To analyze
the data, the total minutes of exercise per week was calculated. Total minutes of exercise per
week was compared at baseline and at week 12. A paired samples t test was calculated to
compare exercise minutes per week at baseline and at week 12. The mean at baseline was
113.2 (SD = 185.14659) and the mean at week 12 was 195 (SD = 238.98825). No statistically
significant difference from baseline to week 12 was found (t (13) = -1.043, p > .05).
Relaxation Technique Usage. The participants were educated about relaxation
techniques such as a meditation, deep breathing, and progressive muscle relaxation as part of
the intervention. Data were collected on relaxation usage at baseline and again at week 12
based on patient responses on the patient questionnaire. They were asked if they performed
any relaxation techniques, and were given examples, with a yes or a no response. If they
responded yes, they were asked how many times per week they perform relaxation techniques
and for how many minutes. These data were totaled to get reported minutes per week of
relaxation techniques. A paired samples t test was calculated to compare minutes utilizing
relaxation techniques per week at baseline and at week 12. The mean at baseline was 7.6 (SD
= 14.22677) and the mean at week 12 was 155.9 (SD = 248.71159). A significant increase from
baseline to week 12 was found (t (13) = -2.220, p = 0.45).
CBT App Usage. The participants were educated about the importance of cognitive
behavioral therapy as a treatment for GAD. They were provided access to an app with CBT
techniques and given step by step instructions on how to obtain access and utilize the app. The
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participants were asked whether or not they implemented CBT and if so, how many days and
for how many minutes they used it at baseline and at week 12. No participants in the project
utilized CBT before the protocol was initiated. A paired samples t test was calculated to
compare CBT usage in minutes per week at baseline and at week 12. The mean at week 12
was 21.6 (SD = 40.22171). No significant difference from baseline to week 12 was found (t (13)
= -2.013, p > .05).
Upon inquiring about CBT app usage at follow up visits, many participants found the
CBT application helpful. Many participants enjoyed the relaxation videos found in the “chill zone”
tab. One patient reported, “hey, that app really does work!”.
Benzodiazepine Usage. Benzodiazepines have been found to be addictive and are
generally reserved for use for short periods of time or with treatment refractory individuals and
are not first-line treatment for GAD (Ministry of Health, 2015; Slade, 2019). Half (n = 7) of the
participants who completed the project were prescribed and used benzodiazepines at baseline.
Only three participants were using benzodiazepines by week 12. The participants reported
benzodiazepine usage on the patient questionnaire at baseline and 12-week follow up. They
were asked if they used benzodiazepines using a yes or no format. If they responded yes, they
went on to answer what benzodiazepine they used, at what dose and how many times per week
they used the medication. A paired samples t test was calculated to compare mg per week used
at baseline and at week 12. The mean at baseline was 0.63 (SD = .89916) and the mean at
week 12 was .17 (SD = .48288). No statistically significant difference from baseline to week 12
was found (t (12) = 1.937, p > .05).
SSRI Prescriptions. SSRIs are first-line treatment for GAD due to their efficacy and
tolerability (Slade, 2019). Participants were educated on SSRI therapy including mechanism of
action, side effects and directions on administration. Providers were educated about prescribing
SSRIs. Prior to implementation, of the 14 patients that completed the project, 10 participants
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were on no antidepressants for GAD, two (14.29%) were already on SSRI therapy, and two
were on an SNRI. During implementation, nine participants (64.29%) were placed on an SSRI.
One patient refused pharmacologic therapy. The two patients that were already on SSRI or
SNRI therapy were kept on their regimen or the dose was increased if appropriate. After
implementation, the percentage of participants prescribed an SSRI went up to 78.57%. This is a
statistically significant difference (t (13) = -4.837, p = .000) from baseline SSRI prescriptions (M
=.1429, SD = .36314) to post-intervention (M =.7857, SD = .42582). Table 4 displays the paired
samples t -test results for the secondary outcomes.
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Table 4
Paired Samples t-tests for Secondary Outcomes
Variable

Mean

SD

t

p

Baseline

113.2143

185.14659

-1.043

.316

12-weeks

195

238.98825

Baseline

7.6429

14.22677

-2.220

.045*

12-weeks

155.9286

248.71159

Baseline

2

2.88675

1.753

.105

12-weeks

.6923

1.93152

Baseline

.1429

.36314

-4.837

.000*

12-weeks

.7857

.42582

Exercise Usage

Relaxation
Technique Usage

Benzodiazepine
Usage

SSRI
Prescriptions

Note. * signifies statistical significance
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CHAPTER 5
DISCUSSION
The aim of this project was to evaluate the effect of a GAD protocol with combination
therapy of pharmacologic therapy with education provided through written and verbal
transmission, CBT via smartphone app and SSRIs. The protocol was implemented with the
desired outcomes being improved anxiety and depression symptoms, increased amount of time
utilizing CBT, relaxation techniques, exercise, increased SSRI prescriptions, and decreased
benzodiazepine use. This chapter will provide an explanation and interpretation of project
findings, strengths and limitations of the project, and implications for the future.
Explanation of Findings
The statistically significant findings provide supporting evidence for implementation of
protocols inclusive of SSRI pharmacologic therapy, CBT via smartphone app, and education in
the primary care setting for treatment of adult patients with GAD. Results from this EBP project
were consistent with current literature regarding treatment of patients with GAD.
Participants
Females accounted for 87.5% of the participants within this project. This correlates with
the evidence that GAD is more common in women than men (DynaMed, 2018). Most (91.7%) of
the sample population were Caucasian. This was an expected finding due to the fact that GAD
is more common in Caucasian individuals and the population of the town in which this project
was implemented is predominantly (95.5%) Caucasian (DynaMed, 2018; United States Census
Bureau, 2019). A risk factor for GAD is low socioeconomic status (DynaMed, 2018). This is
displayed in the demographic results of this EBP project because the most common response of
participants for annual household income level was less than $20,000 (25%). This provides
evidence that GAD may be linked to low socioeconomic status. Many participants (45.9%) had
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either no insurance coverage or government issued insurance. Lack of employment is also a
risk factor for GAD. 12.5% of participants in this project were unemployed.
Anxiety Symptoms
There was a statistically significant decrease in anxiety symptoms based on GAD-7
scores from baseline to eight weeks and from baseline to 12 weeks. Mean GAD-7 scores
among the 14 participants who completed the 12 week follow up decreased as well. According
to GAD-7 scoring, the participants went from having moderate symptom severity at baseline to
having minimal symptom severity at week 12. Some (14.29%) of the participants were already
taking SSRIs prior to implementation of the project, so this indicates the improvement that
education and CBT via smartphone application can have on GAD-7 scores and consequently
anxiety symptoms. Patients reported improvement with symptoms such as feeling nervous,
worrisome anxious, restless, annoyed and irritable based on their responses to the individual
GAD-7 questions. A statistically significant GAD-7 decrease indicates that there is a significant
benefit to implementing a GAD protocol to lessen patients’ severity of GAD symptoms.
It has been noted in the literature that education can be effective to reduce anxiety
symptoms by increasing knowledge about contributing and relieving factors of anxiety (Andrews
et al., 2018; Ministry of Health, 2015). The project protocol involved education about avoiding
contributing factors of anxiety such as caffeine, alcohol, nicotine, and also relieving factors of
anxiety such as exercise, relaxation techniques and healthy diet. Many participants noted on
patient interviews that avoiding the contributing factors and increasing the relieving factors were
helpful for anxiety symptoms.
CBT via smartphone application is superior to in person CBT due to its greater
accessibility and costs (Andrews et al., 2018; Ministry of Health, 2015; Yu et al., 2018). This
project provided further evidence toward this information because before CBT via smartphone
app was implemented as part of this protocol, none of the participants had access to CBT. As
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shown by the demographic data, many participants were of low socioeconomic status, so the
cost of in person CBT may have been too great for them to afford as well. A free CBT smart
phone app gave participants a cost-effective way to access CBT. CBT is effective because it
helps patients change the dysfunctional thoughts, emotions and behaviors that are involved with
the GAD process (Andrews et al., 2018; Yu et al., 2018). The patients can also track their
symptoms levels and know when to seek help. (Andrews et al., 2018). The results of decreased
anxiety in this project are also likely due to these processes. The participants were instructed by
the app to type in their maladaptive thoughts, walked them through what type of “thinking trap”
this was, and helped them create a healthier thought in the thought journal section of the app.
It is assumed that the SSRI prescriptions helped with reduction of the patients’ anxiety
symptoms. SSRIs are first line treatment for GAD due to their relatively low cost, efficacy
evidence in various RCTs, safety and low misuse potential (Andrews et al., 2018; Ministry of
Health, 2015). SSRIs help to reduce the frequency and intensity of panic attacks, reduce
anticipatory anxiety and improve associated depressive mood (Ministry of Health, 2015). In this
project, all participants had the financial means to obtain a prescription for an SSRI. Similar to
the literature findings (Slee et al., 2019 project participants had fairly mild side effects.
Subjectively during follow up visits, few patients did discuss side effects such as sexual
dysfunction, gastrointestinal side effects, and unusual dreams. Often, the participants reported
that the benefit they felt in their anxiety symptoms outweighed the hinderance from side effects.
The protocol did not favor one particular SSRI for primary use because the literature does not
indicate that any one SSRI is superior to the others (Andrews et al., 2018; Ministry of Health,
2015). This may have helped with patient satisfaction and overall result in a reduction in anxiety
symptoms because participants felt some level of control over which medication they were
prescribed. For example, if the medication worked for the participant’s mother, the participant
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felt more comfortable taking the medication and had more faith that the medication would work
for him/her as well.
Depression Symptoms
Depression symptoms measured by the PHQ-9 scale showed statistically significant
decrease over the course of the 12-week implementation period. Mean PHQ-9 scores
decreased from baseline to week four, eight and week 12. Based on the scoring of PHQ-9 this
indicates that due to implementation of the protocol, participants went from moderate
depression symptom severity at baseline to mild depression symptom severity at week four and
then maintained that level of severity for the remainder of the duration of implementation. This
demonstrates not only symptom reduction, but sustainability of symptom reduction over time. A
statistically significant PHQ-9 decrease indicates a strong correlation between a decrease in
severity of depression symptoms and implementation of this protocol. Andrews et al. (2018)
discussed the importance of screening for depression in conjunction with screening for anxiety.
This was demonstrated in this EBP project as many patients who presented with anxiety
symptoms met the criteria for diagnosis of major depressive disorder as well. This protocol was
able to help with both anxiety and depression symptoms as these often occur as comorbid
conditions. It is likely the addition of an SSRI which is an antidepressant medication contributed
to the benefit of decreased depression symptoms due to their effects on serotonin levels in the
brain. Also, the education component which included information about techniques such as
exercise which can increase endorphins and improve mood (Lizarondo, 2020).
Exercise Usage
Although a statistically significant increase in exercise usage was not achieved upon
completion of this project, mean weekly exercise minutes did increase from baseline to week
12. It Is anticipated that the time of year questionnaires were completed had an impact on
results. Being that the project was implemented in Northeast Indiana, weather has a big impact
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on the ability of individuals to safely and comfortably exercise outside. The first questionnaires
were completed at the beginning of implementation, which for most participants was in the
summer and fall seasons when outside exercise is more feasible. The week 12 questionnaires
were distributed to most participants in the winter months when outside exercise is more
challenging. Given this information, it is impressive that participants’ mean weekly exercise
minutes did increase from baseline to week 12. Lack of physical activity is associated with
higher levels of anxiety, and conversely physical activity has been shown to improve mood and
reduce anxiety (Lizarondo, 2020). The reason for this increase in amount of exercise performed
per week can be correlated with the education that was given to the patients regarding exercise
and its importance and efficacy in decreasing anxiety symptoms. It is recommended that all
patients with GAD receive education about lifestyle modifications that are relieving factors of
anxiety symptoms (Andrews et al., 2018; Ministry of Health, 2015). Increased exercise can lead
to better GAD control, as well as weight loss and prevention or improvement of other disease
states such as diabetes mellitus and cardiovascular disease.
Relaxation Technique Usage
The literature states that nurses and general practitioners can appropriately educate
patients about breathing control and relaxation techniques (Ministry of Health, 2015). The EBP
protocol included education on different relaxation techniques. Relaxation techniques work
because they can reduce physical symptoms of anxiety (Andrews et al., 2018; Lizarondo, 2019).
Relaxation technique usage was measured in weekly minutes reported by participants on the
patient questionnaire. A statistically significant increase was found from baseline to week 12.
These data demonstrate that participants increased their coping abilities to stressful situations
likely due to the education about relaxation techniques that was implemented in the protocol. It
is suspected that because the participants were instructed to use relaxation techniques when
they felt anxious or had physical symptoms, they used these positive coping mechanisms more

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

57

often from baseline to the 12 week follow up. Relaxation techniques are a self-care tactic that
can have a positive impact on wellbeing (Andrews et al., 2018; Ministry of Health, 2015). Many
patients indicated that they were doing meditation, yoga, progressive muscle relaxation, and
praying. Some patients verbalized the positive impact that these relaxation techniques had on
their stress levels and ability to fall asleep upon patient interview. Therefore, project findings
support that education on relaxation techniques to increase these healthy habits in participants.
CBT App Usage
CBT has been found to effectively manage GAD symptoms (Andrews et al., 2018;
Berger et al., 2017; Jayasekara, 2016; Ministry of Health, 2015; Yu et al., 2018) However,
access, time constraints and cost are huge barriers to patients receiving CBT (Lizarondo, 2018).
Smartphones can be an avenue for CBT. CBT administered via smartphone has been shown to
improve mood and well-being for patients with GAD (Lizarondo, 2018). No participants in the
project were implementing CBT in any form at baseline. The mean usage at week 12 was 21.6
minutes. Therefore, patients were using CBT more at the end of implementation than at
baseline. The literature reported that the more frequent the use of CBT, the better results
tended to be, while a patient should at least be utilizing the therapy once weekly (Andrews et al.,
2018; Yu et al., 2018). While some patients reported that they really enjoyed the application,
one patient reported that she was worried about cyber security when using the app. She was
worried that her personal thoughts would somehow end up not being private and being shared
by the app users. Another barrier to CBT via smartphone application is lack of access to a
smartphone. One patient did not have access to a smartphone and so was not able to utilize the
application. It is also anticipated that lack of remembering to download the app and time
constraints could have affected ability to obtain significant results in this project. During the first
visit, the provider can ensure that participants can download the app, introduce the app, and
build rapport (Lizarondo, 2018). Some patients who did not download the application in the
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office during the visit reported on their four-week visit that they forgot to get the application.
Therefore, downloading of the app in the office upon baseline visit may be helpful to obtain
significant results. A weekly text to the patient could be used to reinforce app use and offer
encouragement (Lizarondo, 2018). This was not implemented in this protocol and if it were, may
have increased compliance of usage of the app. Many of the participants went from no access
or utilization of CBT to using the application at least once per week, which is what was indicated
as best practice in the literature (Andrews et al., 2018)
Benzodiazepine Usage
Although a statistically significant decrease in benzodiazepine usage was not shown, mg
per week of benzodiazepines usage did decrease from baseline to week 12. Half of participants
who completed the project were using benzodiazepines at baseline, whereas at completion of
the project only three (21.4%) participants were using them. Decreasing benzodiazepine usage
is of benefit to patients as benzodiazepines have been linked to abuse potential and significant
adverse effects such as respiratory depression and confusion in the elderly (Andrews et al.,
2018). Many patients reported that they felt as though the benzodiazepines that they were
prescribed just treated the symptoms, whereas the SSRI prevented the anxiety symptoms from
occurring. This is congruent with the literature. It is reported that SSRIs are as effective as
benzodiazepines, have a broader spectrum of action and have less of a potential for abuse
(Ministry of Health, 2015). Upon patient interview at follow up visits, some patients were not
satisfied with their level of anxiety control with benzodiazepines and were more satisfied with
SSRIs efficacy. GAD protocols can be linked to decrease benzodiazepine use and therefore
should be utilized.
SSRI Prescriptions
The literature displayed that SSRIs are first line treatment for GAD (Andrews et al.,
2018; Ministry of Health, 2015; Slade, 2019, Slee et al., 2019). This is because SSRIs are low-
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cost options that have been found to be effective in reducing anxiety symptoms while also being
well tolerated (Andrews et al., 2018; Ministry of Health, 2015; Slade, 2019). SSRI prescriptions
did increase as a result of implementation of this GAD protocol. Of the 14 patients that
completed the project, 10 participants were on no antidepressants for GAD at baseline. Two
(14.29%) were already on SSRI therapy, and two were on an SNRI medication. During
implementation, nine additional participants (64.29%) were placed on an SSRI. After
implementation, the percentage of participants prescribed an SSRI was 78.57%. This increase
of SSRI prescriptions is a triumph. SSRIs do not have the abuse potential that benzodiazepines
do, and therefore can be safer for patients (Andrews et al., 2018; Ministry of Health, 2015;
Slade, 2019). The number of SSRI prescriptions went up during this project, which could
inversely correlate with the decrease in anxiety symptoms. Implementation of a GAD protocol
can increase prescribing of SSRIs which have been reported in the literature as being safe and
effective pharmacologic therapy.
Strengths and Limitations of the EBP Project
Strengths
One strength of this project was that it offered a cost effective, easily accessible means
of obtaining CBT. There is a shortage of mental health care providers and demand is far greater
than supply of providers creating a gap in mental health care services such as CBT (Lizarondo,
2018). Providing access to CBT for patients that is effective, safe, secure and can be utilized in
their own home at zero cost can close some of those gaps. Another strength of the project is
that the clinical decision tool provided guidance to providers to refer patients who would be
more appropriately treated in a psychiatric care setting than in primary care. This acceptance of
the limitation of treatment in the primary care setting provides safer care for those high-risk
patients. Before the project was implemented, the providers had some ambiguity about who
should be referred and who could be appropriately addressed in the primary care setting. This
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clinical decision tool acts a guide to make clear the patients who should be referred. Another
strength of this project was the increase of prescribing practices that correlate with best practice
for treatment of GAD. Less benzodiazepines were used as a result of this project and more
SSRIs were prescribed, which matches the recommendations of the high-quality evidence.
Using the JHNEBP model was a good resource utilized during this project. The model was a
guide for all the steps of the EBP process, and it was referred to ensure that the process was
being done appropriately. Another strength of the project was good buy-in from the site
facilitator and the other nurse practitioner. They often would initiate the protocol with patients
who they felt appropriate to initiate it for, even if the patient could not be included in the project
due to meeting exclusion criteria. For example, the nurse practitioners were often initiating the
protocol with teenagers. The teenagers seemed impressed with the CBT app especially, likely
related to their technology expertise. The nurse practitioners would ask the DNP student to
educate patients that were not diagnosed with GAD but had a procedure and seemed a bit
anxious about it. It was realized throughout this project that many patients could benefit from
education about self-care techniques and CBT.
Limitations
There were limitations to this project. The participant size of this project was relatively
small compared to the existing evidence within the literature review. This is not reflective of the
high prevalence rate of GAD. The participant size was limited by availability of the DNP student
for recruitment who was the only person who recruited participants. The site facilitator saw
many more patients with GAD symptoms on days when the DNP student was not present. This
contributed to potential participants that were missed. This was due to lack of time in the site
facilitators schedule to perform chart review to determine eligibility, collect demographic data
and initial patient questionnaires. This could be mitigated in future projects by teaching support
staff to provide education and CBT information. The inclusion and exclusion criteria were
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another contributing factor for the small participant size. Patients who were under 18, pregnant,
non-English speaking, suicidal, homicidal, having active psychosis, and/or had concurrent
alcohol or drug abuse were excluded from the EBP project. There were multiple teenage
individuals that were treated for GAD during the implementation period, but data were not
recorded because of these criteria. The literature does recommend that children be treated with
CBT adapted for their age group but recommend that psychiatric advice be sought before
prescribing medication for children and adolescents (Andrews et al., 2018). In the primary care
setting, a provider could implement the education and CBT portion and then refer to psychiatry if
symptoms are continuing to be unmanaged. One pregnant woman was provided with a modified
version of the protocol with education and CBT implemented. Again, this abbreviated protocol
could be implemented, and then referral to OBGYN or psychiatry could be facilitated for
pharmacologic management on these patients. These data also were not collected due to
exclusion criteria. The other exclusion criteria were not hinderances on sample size during this
project. Another barrier was the lack of support from the physician in the office, which limited
patients who were able to be recruited for the project. He did not participate due to time
constraints in his schedule and resistance to change.
Another limitation was the frequency of follow up with participants. It was recommended
in the literature that treatment should be reviewed after 4-6 weeks of CBT and
pharmacotherapy, so the protocol followed this recommendation (Andrews et al., 2018). This
same four week interval was continued for 12 weeks. Although this provided a lot of data and
gave information about when the protocol was effective and whether it remained effective over
time, it was fairly time consuming for the DNP student and might not be feasible for the
providers at the office to maintain such close follow up repetitively. When patients report
improvement of symptoms, it then may be appropriate to extend the follow up interval. Also,
follow up intervals weren’t very individualized. For example, some patients were experiencing
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such great improvement on their week four follow up, that it probably would have been more
appropriate to extend the interval of time out further than four weeks for their next follow up. The
literature is vague on the topic of follow up intervals after achieving remission of symptoms. The
literature states that follow up should occur “regularly but not too often” (Andrews et al., 2018).
However, for other participants, who did not see such great results, had intolerable side effects
or worsening of symptoms at their four week visit, they could have been switched to a different
SSRI at a sooner date. The literature does state that patients can initially be seen weekly to
monitor for adverse effects and worsening of symptoms (Andrews et al., 2018).
Another limitation of this project was the lack of standardized measurement for
qualitative evidence. While participants did give verbal feedback regarding interventions during
follow up visits, this information was purely random and not standardized using a tool or form. I
would have created a form that asked for feedback on things such as ease of use of app,
whether the participants feel as though their current level of anxiety is manageable, which selfcare techniques they feel like work and if they had any negative responses to any of the
components. I would have administered this form at the 12 week follow up visit.
Additionally, the COVID-19 pandemic was ongoing for the duration of this project. This
impacted participants’ level of symptoms due to the stress and uncertainty surrounding the
virus, employment, ability to access healthcare and other services such as exercise facilities.
This could have negatively impacted results of this project.
Implications for the Future
This EBP project produced information for health care providers about the effects of a
protocol for GAD that included combination therapy with SSRIs, CBT via smartphone app, and
education. Implications for the future related to practice, theory, research and education will be
discussed.
Practice
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While combination therapy utilizing SSRIs, CBT, and education is first line for treatment
of GAD, not all providers treat patients in clinical practice with this evidence-based approach.
This project allowed for evidence to drive the treatment of GAD at this particular clinic. It is
recommended that all primary care offices adopt this protocol due to its accessibility, low cost
and effectiveness. SSRIs are typically inexpensive; education does not have any additional
financial costs during the visit and CBT administered via Mindshift app is free to download.
Therefore, minimal budgeting is necessary for further continuation of this project. Implementing
a protocol with such extensive education can be time consuming for the nurse/provider to
perform. To combat this barrier, increasing appointment times for initial visits for anxiety
complaints can help facilitate continuation of this protocol and the extensive education portion.
The nurses and medical assistant at this particular clinical setting are going to administer the
education and review the CBT information with patients who have an anxiety related chief
complaint or as indicated by the provider. This could be built into the electronic health record
that if the nurse types in a psychiatric chief complaint, a prompt fires that they should administer
the PHQ-9 and GAD-7 assessments. Based on the results of the assessment, they would
receive another prompt to facilitate the protocol.
EBP Model
Use of the JHNEBP model as the guide for this project allowed for a stepwise approach
to successfully implementation. The model starts with inquiry, which is desire to learn about and
implement best practice. Then, the PET process occurs where the planning, evidence, and
translation of the change occurs. Getting started with the EBP process was daunting for the
DNP student and was further compromised by the COVID-19 pandemic interrupting in person
sessions. Because of this, the first phase was the most helpful for the DNP student. The first
phase involves generating an interprofessional team, defining the problem, developing and
refining the EBP question, identifying stakeholders, determining responsibility for project
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leadership and scheduling team meetings. This could be considered the planning step. The
DNP student was new to the process of EBP, and so a stepwise approach to start out was
helpful. The JHNEBP model also allowed for the DNP student to realize that EBP is a fluid and
continual process that is never complete. Best practice turns into practice improvements but
those lead right back into inquiry to continue more EBP. The weakest part aspect of this model
is that the model is designed for individual nurses to be a part of EBP processes and less about
organizational changes, which was the main focus of this project.
Research
Further research is needed in specific areas of GAD treatment. Upon extensive review of
the individuals results from this project, it was noted that the patients who seemed to benefit the
most from this protocol were patients who were newly diagnosed with GAD or who had not been
attempted on pharmacologic therapy before. These patients GAD-7 and PHQ-9 scores tended
to decrease the most. Results did not seem as strong for patients who had more treatment
refractory symptoms such as the patients who had tried many antidepressants inclusive of
SSRIs in the past. It was also harder to choose an SSRI option that the patient had not been
prescribed before. This sparked the spirit of inquiry for the DNP student. More research needs
to be done about the treatment of treatment refractory GAD and how best to improve outcomes
in these patients. Further research is also needed to refine whether there is a best SSRI for
treatment of GAD, or whether there are certain SSRIs that should be prescribed for certain
individuals. More research should be done about the effects of CBT administered via
smartphone app. It is a relatively new intervention that does not yet have a large body of
evidence supporting it. However, technology is becoming more popular in healthcare, so this
research is necessary. Additional research should be performed about exercise in GAD
including how much they should be performing and comparing the types of exercise. Similarly,
more research should be conducted about education and how best that is to be provided to
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patients for best absorption of information. A consensus on follow-up intervals should be arrived
at to decrease the ambiguity regarding when a patient should be monitored so it is more
individualized to the patient’s level of symptoms.
It is also recommended that future projects related to GAD try to enhance sample size of
the project for more statistical power. It would also be beneficial to implement this protocol on a
more diverse population to see what effect this diversity has on results and to improve
generalizability.
Education
Education was a direct component of this EBP project. It was demonstrated that
education had an impact on both providers and participants. The increased prescriptions for
SSRIs and the decreased prescriptions for benzodiazepines suggest that education about SSRI
prescribing had an effect on prescribing habits of the providers to more closely match high
quality evidence recommendations. The fact that none of the participants were utilizing CBT at
baseline, whereas some were prescribed SSRIs, provides evidence that knowledge about CBT
and modalities in which it can be utilized was lacking. Education about CBT and that it can be
administered via smartphone app was helpful to providers as well as participants. This is shown
by the vast increase from zero patients having access to CBT at baseline to 13 of the 14
patients having access and the number of minutes per week of use increasing. The providers in
the office expressed that they were unaware that CBT was available through smartphone apps.
With the implementation of this protocol, more patients will have access to this first-line
treatment. Increased amount of time spent exercising, using the CBT app, and doing relaxation
techniques demonstrates that education about these modalities had an impact in participants’
lifestyle habits and coping skills. Statistical significance was found with relaxation techniques but
was not arrived at with exercise.
Conclusion

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

66

GAD is a very prevalent disease that can cause significant symptoms and distress for
affected patients. Using the JHNEBP model, the DNP student began with an extensive literature
search that showed best practice for treatment of GAD is combination therapy with SSRI
pharmacotherapy, CBT administered via smartphone application and education. A protocol was
created inclusive of these modalities. As part of the protocol a clinical decision tool and
education on SSRIs were given to providers in the office. The project demonstrated a
statistically significant decrease in anxiety and depression symptoms for patients, as well as
increased relaxation technique usage. These findings are consistent with current literature.
Mean exercise, and weekly minutes of CBT usage increased over the course of this project,
indicating an increase in positive coping strategies. This EBP project has improved symptoms
for patients as well as the prescribing practice of providers at the project site. More SSRI
prescriptions and less benzodiazepine prescriptions were provided to patients over the course
of this project. Efforts for sustainability were necessary during the implementation period.
Copies of the handouts were provided to the office for post-project use. Providers and staff were
trained on how to implement the protocol after the project concluded. The providers and staff
were receptive to continuing the new practice and have plans to implement the protocol now
that the project is complete. Given this project’s encouraging findings, it is recommended that
other primary care offices implement a GAD protocol in order to improve symptoms for patients
using this cost-effective, accessible and effective method.
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ANOVA: Analysis of Variance
CBT: Cognitive Behavioral Therapy
CITI: Collaborative Institutional Training Initiative
CPG: Clinical Practice Guideline
DNP: Doctor of Nursing Practice
DSM-5: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
EBP: Evidence-Based Practice
GAD: Generalized Anxiety Disorder
GAD-7: Generalized Anxiety Disorder 7-item Scale
ICBT: Internet Cognitive Behavioral Therapy
JBI: Joanna Briggs Institute
JHNEBP: John Hopkins Nursing Evidence-Based Practice
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PET: Practice Evidence Translation
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SSRI: Selective Serotonin Reuptake Inhibitor
PHQ-9: Patient Health Questionnaire 9-item Scale
PSWQ: Penn State Work Questionnaire
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APPENDIX A
Evidence Table
Citation (APA)

Purpose

Design

Sample

Andrews, G., Bell, C., Boyce, P.,
Gale, C., Lampe, L., Marwat, O.,
Rapee, R., & Wilkins, G. (2018).
Royal Australian and New
Zealand college of psychiatrists
clinical practice guidelines for
the treatment of panic disorder,
social anxiety disorder and
generalised anxiety disorder.
Australian and New Zealand
Journal of Psychiatry, 52(12),
1109-1172.

To provide
guidance for
health care
providers on
how to treat
adults with
panic
disorder,
social anxiety
disorder or
GAD.

Clinical
practice
guideline

The target
population is
adults aged 1865 with mild,
moderate,
severe and
treatment
refractory panic
disorder, social
anxiety disorder
or GAD.

Discusses the
assessment,
diagnosis and
treatment of
GAD.
Treatment of
GAD
recommended
starts with
education and
lifestyle
measures and
then moves to
CBT, SSRIs
and SNRIs.

A thorough
literature
search was
performed.
143 quantitative
studies were
included in the
qualitative
synthesis. Only
meta-analyses
or systematic
reviews of
RCTs were
included.

Measurement
/Outcomes
Improvement of
symptoms
typically begins
to occur
between 4-6
weeks after
starting CBT or
medication
treatment so
treatment should
be assessed
then. Patients
should “be seen
weekly to
monitor
adherence,
adverse effects,
and to identify
worsening of
symptoms until
there is a
response and
symptoms have
stabilised”
(p.1124).
GAD-7 or
PSWQ-3 is

Results
/Findings
Education
about the
nature and
treatment of
GAD and
lifestyle factors
is
recommended.
Select initial
treatment with
consideration
to patient
preference,
cost,
accessibility,
tolerability and
safety.
Initial treatment
options: CBT
guided dCBT,
or SSRI (or
SNRI), or the
combination of
both.

Level
/Quality
Level I
High
quality

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

73
recommended
as a self-report
measure for
GAD.

Berger, T., Urech, A., Krieger,
T., Stolz, T., Schulz, A., Vincent,
A., Moser, C. T., Moritz, S.,
Meyer, B. (2017). Effects of a
transdiagnostic unguided
internet intervention (‘velibra’)
for anxiety disorders in primary
care: Results of a randomized
controlled trial. Psychological
Medicine, 47, 67-80.
doi:10.1017/S00332917160022
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To explore
whether
unguided
internetbased CBT
(ICBT) is
effective in
primary care
settings in
reducing
anxiety
symptoms
when
compared to
care as usual.

Randomized
controlled trial
Participants
were randomly
assigned to
two groups:
the immediate
treatment
group which
consisted of
CAU plus
ICBT and an
active waitinglist control
group who
received care
as usual.

139 adult
participants
were included,
some heard
about the study
from their
provider, while
others visited
the study
website and
asked to be in
the study.
70 were in the
experimental
group, 69 were
in the control
group

Participants
completed
disorderunspecific selfreport measures
at pre-treatment,
post-treatment in
9 weeks, and
follow-up at 6
months.
Primary
outcome
measures:
Depression
Anxiety Stress
Scales – Short
Form, the Beck
Anxiety
Inventory, the
Beck
Depression
Inventory-II, the
Brief Symptom
Inventory and
the Short-Form
Health Survey12

Depending on
response, keep
therapy the
same or modify
therapy after 46 weeks.
44.8% of
participants
with a GAD
diagnosis at
pre-treatment
no longer
fulfilled
diagnostic
criteria at posttreatment for
GAD in the
experimental
group, whereas
0% recovered
in the control
group.
There were
statistically
significant
results in posttreatment
between group
comparisons
for most
primary
outcome
measures (p <
0.01).

Level II
Good
quality

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

Jayasekara, R. (2016).
Evidence Summary: Anxiety
disorders: Psychotherapy. The
Joanna Briggs Institute, 1-3.

To determine
the best
evidence
regarding
psychotherap
y for patients
with GAD

Evidence
summary
Psychotherapy
interventions
such as CBT
were utilized in
the studies
and
summarized in
the evidence
summary.

Children,
adolescents,
adults, and
older adults
with GAD
2 Cochrane
systematic
reviews, 2
systematic
review, 4 RCTs,
1 meta-analysis
and an RCT
pilot study were
included in the
sample.
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Secondary
outcome
measures:
disorder specific
instruments
such as the 16item Penn State
Worry
Questionnaire
and Client
Satisfaction
Questionnaire.
The effect of
CBT on anxiety
levels, relapse of
anxiety
symptoms, and
symptoms of
worry and
depression were
measured.

CBT is
effective in
reducing
anxiety levels,
relapse of
anxiety
symptoms, and
symptoms of
worry and
depression and
improvement in
overall mental
health.
CBT was
effective in
reducing
symptoms and
those results
were
maintained at
12-month
follow-up.

Level I
High
quality
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Lizarondo, L. (2018). Evidence
Summary: Anxiety: Smartphonebased interventions. The
Joanna Briggs Institute, 1-3.

To determine
the best
evidence
regarding the
effectiveness
of
smartphonebased
interventions
for the
management
of anxiety

Evidence
summary

Patients with
anxiety

Psychological
interventions
accessed via
smartphone
were
discussed in
the evidence
that was
summarized.

1 systematic
review, 1 RCT
and a pre-post
study were
included in the
sample.
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The effect of
smartphone
based
psychological
interventions on
depressive or
anxiety
symptoms were
measured.

Patients with
anxiety should
be offered the
option to use
their
smartphone to
access
psychological
interventions to
manage their
anxiety
symptoms in a
(grade B
recommendatio
n).

Level III
High
quality

Smartphonebased apps
can be a way
to give access
to CBT for
patients with
barriers.

Lizarondo, L. (2019). Evidence
Summary: Anxiety disorder:
Relaxation therapy. The Joanna
Briggs Institute, 1-2.

To determine
the best
evidence
regarding the
effectiveness
of relaxation

Evidence
summary
Relaxation
therapy
including

Patients with
anxiety
disorders such
as GAD, panic
disorder, social
anxiety

The effect of
relaxation
therapies on
reduction of
symptoms of
anxiety,

An introductory
meeting to
explain app
use may be
warranted for
patients.
Relaxation
therapies can
be used to
reduce
symptoms in
patients with

Level I
High
level
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for the
management
of anxiety
disorders.

Lizarondo, L. (2020). Evidence
Summary: Generalized anxiety
disorder: Exercise. The Joanna
Briggs Institute, 1-2.

To determine
the best
evidence
regarding the
effectiveness
of exercise for
GAD

progressive
muscle
relaxation,
applied
relaxation,
autogenic
training, and
mindfulnessbased therapy
and meditation
were
discussed in
the evidence
that was
summarized.

disorder, and
specific
phobias.
2 systematic
reviews
involving 66
RCTs
combined were
included in the
sample.

Evidence
summary

Patients with
GAD

Physical
exercise
including
resistance
exercise, nonaerobic and
aerobic
exercise were

2 systematic
reviews, and 2
clinical practice
guidelines were
included in the
sample.

76
depression,
phobia or worry
and comparing
CBT with
relaxation
therapy were
measured.

The effect of
exercise on
improvement of
symptoms of
GAD and quality
of life were
measured.

anxiety
disorders
(grade A
recommendatio
n).
In one
systematic
review, there
was no
significant
difference
found between
relaxation
therapy and
CBT.
Applied
relaxation was
found to be
more effective
than
progressivemuscle
relaxation.
Exercise can
be added to
usual care of
patients with
GAD to
decrease
symptoms and
improve quality
of life (grade B
recommendatio
n).

Level I
High
level
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discussed in
the evidence
that was
summarized.
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Exercise can
improve
symptoms of
anxiety.
A significant
improvement in
GAD
symptoms in
both the
aerobic and
non-aerobic
exercise group.
Although,
exercise has
been
demonstrated
to have
significant
improvements
in GAD
symptoms and
patients should
participate,
there are no
specific
recommendatio
ns for how
long, or what
type of
exercise should
be used in the
guidelines.
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Ministry of Health. (2015, April).
Anxiety disorders.
https://www.moh.gov.sg/docs/lib
rariesprlibrar4/guidelines/cpg_a
nxiety-disorders-apr-2015---fullguidelines.pdf

A guide to be
used by
providers
paired with
their clinical
judgment to
manage
adults with
anxiety
disorders

Clinical
practice
guideline
Discusses
diagnosis,
assessment,
treatment,
referral, and
scales used to
manage a
person with
GAD.
Treatment of
GAD includes
education and
lifestyle
factors, and
then treatment
with SSRIs or
venlafaxine
pharmacothera
py and face to
face CBT is
recommended.

The guideline
provided
recommendatio
ns for patients
with panic
disorder, GAD,
phobias, social
anxiety
disorder,
obsessivecompulsive
disorder, posttraumatic stress
disorder, and
anxiety
disorders in
pregnant
women.
An extensive
literature review
was conducted.

78
Drug treatment
for GAD should
be continued for
at least 32
weeks due to
high relapse
rates if
medications are
discontinued
before then.
The Clinical
Global
Impression
scales may be
used to measure
illness severity
and treatment
progress.
GAD-7 scale
can be used as
a screening
instrument for
GAD and
provides
quantitative data
of the severity of
symptoms.

Diagnosis of
GAD should
only be
considered
after organic
causes are
ruled out.
Primary care
providers are
appropriate for
initial
management of
GAD, but there
are certain
indications for
referral to
psychiatry that
a provider must
be aware of
such as when
there is a
serious risk of
suicide,
psychotic
symptoms, cooccurring
drug/alcohol
problem,
symptoms are
complex, or if
symptoms fail
to improve on
initial treatment
and follow up.

Level I
Good
quality
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After diagnosis,
patients should
be educated on
their disease,
and about
lifestyle
modifications.
Their family
should be a
part of their
care.
SSRIs and
venlafaxine
should be used
first line for
pharmacologic
al therapy.
Benzodiazepin
es should not
be used longterm for GAD
treatment.

Romano, M. (2019). Evidence
Summary: Anxiety disorders:
Self help. The Joanna Briggs
Institute,1-5.

To determine
the best
evidence
regarding

Evidence
summary

Patients with
anxiety
disorders such
as panic

The
effectiveness of
self-help
interventions

CBT should be
used first line
for
psychotherapy
treatment for
patients with
GAD.
Self-help
interventions
may be used
for the

Level I
High
quality
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self-help
interventions
for patients
with anxiety
disorders

Psychological
treatments
such as CBT
administered
independently
in books,
computers,
television,
video or the
internet were
discussed in
the evidence
that was
summarized.

disorders,
social anxiety
disorder,
phobias, GAD,
and posttraumatic stress
disorder.
4 systematic
reviews, 2
RCTs, 5 metaanalyses, and 1
Cochrane
review were
included in the
sample.

80
with symptom
reduction, costeffectiveness
and feasibility
were measured.

treatment of
patients with
anxiety
disorders in a
grade A
recommendatio
-n
Self-help
interventions
are a costeffective way to
manage
anxiety
disorders.
Materials
should be ageappropriate
and should be
administered
over a period of
at least 6
weeks.
Self-help
interventions
such as
internet or
computerbased therapy
have shown
efficacy when
compared to
wait-list and
placebo and
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Slade, S. (2019). Evidence
Summary: Generalized anxiety
disorder: Pharmacotherapy. The
Joanna Briggs Institute,1-3.

To determine
the best
evidence
regarding
pharmacother
-apy for
patients with
GAD.

Evidence
summary

Adult patients
with GAD

Pharmacologic
treatment
typically
combined with
psychological
therapy and
self-care were
discussed in
the evidence
that was
summarized.

9 systematic
reviews, 1
clinical practice
guideline, 1
prospective trial

81

Ability to
promote
remission,
tolerability,
efficacy in
reduction of
symptoms and
response rates
were measured.

equal to
therapistdelivered
treatment.
The use of
antidepressant
s, quetiapine
and pregabalin
were all
recommended
for use, with
clinical
judgment and
patient
preferences in
mind in a grade
A
recommendatio
n.
Fluoxetine was
most strongly
recommended
due to
obtaining
response and
remission.
Sertraline was
most strongly
recommended
for tolerability.
“A lack of
response within
4 weeks of

Level 1
High
quality
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82
antidepressant
use suggests
further
response is
unlikely” (p.1).
Benzodiazeapines should only
be used for
treatment
refractory
individuals.
Combining
CBT with an
SSRI may
allow them to
be weaned
from the SSRI.

Slee, A., Nazareth, I.,
Bondaronek, P., Liu, Y., Cheng,
Z., & Freemantle, N. (2019).
Pharmacological treatments for
generalised anxiety disorder: A
systematic review and network
meta-analysis. The Lancet, 393,
768-777.
http://dx.doi.org/10.1016/
S0140-6736(18)31793-8

To explore
pharmacologi
c treatments
for treatment
of patients
with GAD.

A systematic
review and
network metaanalysis
The
pharmacologic
treatments
discussed in
this review
include 22

A thorough
literature review
was conducted.
89 trials
consisting of
25,441 patients
with GAD were
included in the
review.

Primary
outcomes were
efficacy noted in
mean difference
in change in
Hamilton Anxiety
Scale score and
acceptability
measured by
study

Treatment of
any anxiety
disorder with
propranolol is
ineffective.
Duloxetine,
pregabalin,
venlafaxine,
and
escitalopram
were more
efficacious than
placebo with
good
acceptability.
Mirtazapine,

Level I
High
quality
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different drugs
including
SSRIs, SNRIs
and
benzodiazepines

Yu, J. S., Szigethy, E., Wallace,
M., Solano, F., & Oser, M.
(2018). Implementation of a
guided, digital cognitive
behavioral program for anxiety
in primary care: Preliminary
findings of engagement and
effectiveness. Telemedicine and
e-Health, 24(11), 870-878. doi:
10.1089/tmj.2017.0280

To report
preliminary
data on
engagement
and symptom
improvement
in adult
patients with
anxiety in
primary care
who engage
in a mobile
CBT program,
Lantern.

Preliminary
findings of a
nonrandomized
control trial
A substudy of
a larger twoarm trial at 4
primary care
clinics. 2
clinics serve
as active sites,
offering
Lantern to
study
participants,

83
discontinuations
for any reason.

63 adults aged
20-65 years old
with at least
mild anxiety,
who had a
smartphone or
tablet were
recruited for the
study.

The GAD-7 was
used as a rating
scale for anxiety
symptoms. This
was assessed at
baseline and 2
months after
initiation of
Lantern
Engagement
was assessed
by usage data
from the Lantern
app for each
participant, more
specifically,

sertraline,
fluoxetine,
buspirone and
agomelatine
also were
effective and
had good
acceptability,
but with a
smaller sample
size.
Quetiapine,
paroxetine, and
benzodiazepin
es were
effective, but
not well
tolerated.
Baseline GAD7 score was
11.5 (SD =
4.82), whereas
2-month GAD7 score was
9.4 (SD =
4.94). This was
a statistically
significant
decrease in
symptoms (p =
0.009).
On average, in
2 months,
participants

Level III
Good
quality
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while 2 serve
as control sites
providing
enhanced
treatment as
usual.

84
number of units
were completed,
number of times
a technique was
practiced, and
number of days
the patient
logged in.

used Lantern
18.4 days,
completed 11.2
units and
practiced 16.1
techniques.
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Appendix B
Education Provided to Patients

What is the problem? Generalized anxiety disorder. Generalized anxiety disorder is a common
condition where you have excessive worry and stress for at least 6 months that causes physical
distress and impairs your ability to function. This can be due to an imbalance of chemicals called
neurotransmitters in your brain. Anxiety can cause physical symptoms such as trouble sleeping,
restlessness, muscle aches and tiredness. Anxiety can impact your ability to function throughout
the day.
What should you do? There are many things that you can do to help improve your symptoms.
1.) Cognitive Behavioral Therapy: Cognitive behavioral therapy has been shown in many
different studies to decrease anxiety symptoms. This is one of the best treatments for
anxiety. This therapy tries to improve your way of thinking in order to deal with your
problems in a more positive way. We will be giving you information on a smart phone
application that you should. You should use this at least once per week, but the more you
use it, the better. You could use the application instead of getting on Facebook, during
commercial breaks of a tv show, or when you are waiting for someone or something. You
can get on the application and learn about anxiety, do exercise, and perform relaxation
techniques.
2.) Diet: You should try reducing your intake of caffeine. Caffeine is a stimulant which can
increase your heart rate and make you jittery, which can cause you to feel anxious. You
should increase your intake of fruits, vegetables, and whole grains.
3.) Essential Oils: Lavender, patchouli, clary sage has been found to calm anxiety. You can
place a few drops on your skin every day, you can diffuse it in a diffuser, or put in in your
bath water. You can get essential oils at Walmart, Meijer, Lakeside Farms and Nature’s
Cornucopia in town, or online at places like Amazon.
4.) Exercise: You should perform 30 minutes of exercise per day most days of the week.
Some examples of this could include walking, swimming, biking and/or lifting weights. It
has been shown in research that exercise can decrease anxiety symptoms, help to calm
you down and release tension. It can also help you lose weight and become healthier.
5.) Medications: Your provider may prescribe you a medication called a selective serotonin
reuptake inhibitor. There are 5 medications in this class. Serotonin is a chemical in your
brain that helps with your mood. These medications fight against the “bad guys” stealing
the serotonin from your brain, so that there is more serotonin for you to have, therefore
improving mood and decreasing anxiety. Your provider will tell you when and how to
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take this medication, but it is important that you take it like they tell you and tell them if
you want to stop it or are having side effects.
6.) Relaxation Techniques: You should try to use relaxation techniques as much as possible,
but especially if you notice that your anxiety is flaring up. These techniques do not take
long and could be performed 2-3 times per day. Again, do this instead of getting on social
media applications, during commercial breaks, or while you’re waiting.
a. Progressive muscle relaxation. First, you will take a deep breath and tense a
muscle group for instance your clenching your hands for 4 to 10 seconds. Then,
breathe out and completely relax your hands. Then, relax for 10 to 20 seconds.
Then, move on to the next muscle group such as shrugging your shoulders.
Continue with all of your muscles. When you are finished with all of the muscle
groups, count backward from 5 to 1.
b. Meditation: Sit or lie in a comfortable position. Close your eyes. Breathe
naturally. Focus on your breath and how your body moves with each inhalation
and exhalation. If your mind wanders, return your focus back to your breath.
c. Deep breathing: Take a slow deep breath from your belly, count to 4 as you
breathe in. Hold your breath, and silently count from 1 to 7. Breathe out
completely as you silently count from 1 to 8. Repeat.
7.) Sleep: You should be getting 7-9 hours of sleep at night. Try going to bed at the same
time every night and waking up at the same time every morning.
8.) Smoking and drinking alcohol: Smoking and drinking alcohol can increase your anxiety
symptoms. If you smoke tobacco, you should quit smoking. Nicotine can cause anxiety
to flare up due to its stimulating effects. Ask your provider if you need help with his such
as with patches, medication or counseling. If you drink alcohol, you should attempt to cut
back to 1 standard size drink per day or less for a female or 2 standard size drinks per day
or less for a male. Alcohol can cause a change in the chemicals in your brain called
neurostimulators and can make your anxiety worse.
Resources about Generalized Anxiety Disorder:
National Institute of Mental Health: https://www.nimh.nih.gov/health/topics/anxietydisorders/index.shtml
Anxiety and Depression Association of America: https://adaa.org/understandinganxiety/generalized-anxiety-disorder-gad/treatments
University of Michigan: https://www.uofmhealth.org/health-library/uz2225
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National Suicide Prevention Hotline: https://suicidepreventionlifeline.org or 1800-272-8255
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APPENDIX C
Power Point Provided to Providers
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APPENDIX D
Clinical Decision Tool Provided to Providers

Diagnosis of patient with GAD after
ruling out organic causes following
DSM V criteria. If patient has
symptoms of psychosis, drug and
alcohol addiction or suicidal or
homicidal ideations refer to psychiatry

Assess patient’s level of anxiety and
depression using GAD-7 and PHQ-9

GAD-7 results of 5-9
indicates mild
severity

GAD-7 results of 1014 indicates
moderate severity

GAD-7 results of 1521 indicate severe
severity

Initiate education,
CBT via smartphone
application and SSRI
pharmacotherapy

Review response to
initial treatment after
4-6 weeks

If at least partial
response: continue
treatment, monitor
progress and
adverse effects

If no response or worsening of
symptoms: check adherence,
increase medication dose within
approved range, and/or change to
face to face CBT, and/or refer to
psychiatry
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APPENDIX E
Demographic Form

Please answer the following questions about yourself.
1. How old are you? ____________________
2. What is your sex?
a. Male
b. Female
c. Other
3. What is the highest level of education that you have completed?
a. Less than high school
b. High school/GED
d. Some college with no degree
e. 2-year college degree (Associates)
f. 4-year college degree (Bachelors)
g. Master’s degree
h. Doctoral degree
4. What is your race?
a. African American
b. Asian-Pacific Islander
c. Caucasian
d. Hispanic
e. Native American
d. Other
f. Prefer not to answer
5. What form of health insurance do you currently have?
a. No insurance
b. Medicare
c. Medicaid
d. Private insurance
6. What is your marital status?
a. Single
b. Married
c. Separated
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d. Divorced
e. Widowed
7. What is your annual gross household income?
a. Less than $20,000
b. $20,000 to $34,999
c. $35,000 to $49,999
d. $50,000 to $74,999
e. $75,000 to $99,999
d. $100,000 or more
8. What is your current employment status?
a. Employed full time
b. Employed part time
c. Unemployed and currently looking for work
d. Unemployed and not currently looking for work
e. Student
f. Retired
g. Homemaker
h. Self-employed
i. Unable to work/disabled
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APPENDIX F
Handout Provided to Patients about MindShift Application

You should download the MindShift app. This app is available on Apple and Android phones.
This app is free of charge and there are no in app charges.
The application looks like this.

You will then open the app and will have to create an account. Click Create Account.
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This is the information you will have to fill out. This only take a minute.

You can do a daily check in.
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You can set goals using the goals tab.

You can learn about anxiety and cognitive behavioral therapy (CBT) using the learn tab.

95

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

96

You can use the tools in the Home tab. The healthy thinking section helps you retrain your brain
to think healthier thoughts. The chill zone section walks you through many different relaxation
techniques. The taking action section walks you through things you can do to reduce your
anxiety such as eating right, get enough sleep, be active, comfort zone challenges, and facing
fears.
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APPENDIX G
Patient Log Sheet

Reminders:
-Exercise 30 minutes a day. This could include walking, swimming, weight training, bike riding.
-Relaxation Techniques: Use relaxation techniques such as progressive muscle relaxation or deep
breathing whenever you feel like your anxiety is flaring up.
-MindShift Smartphone App: Obtain the application and use at least once a week or whenever
you notice your anxiety flaring up.
Date

Exercise Relaxation MindShift
Missed
Benzodiazepine
(Type,
Techniques Application
Dose of
(Ativan,
Intensity)
(Type)
Medication
Xanax) Use
(Dose)

Time Spent
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APPENDIX H
GAD-7 Scale

GAD-7
Over the last 2 weeks, how often have you
been bothered by the following problems?

More than
Nearly
half the
every day
days

Not
at all

Several
days

1. Feeling nervous, anxious or on edge

0

1

2

3

2. Not being able to stop or control worrying

0

1

2

3

3. Worrying too much about different things

0

1

2

3

4. Trouble relaxing

0

1

2

3

5. Being so restless that it is hard to sit still

0

1

2

3

6. Becoming easily annoyed or irritable

0

1

2

3

7. Feeling afraid as if something awful
might happen

0

1

2

3

(Use “

” to indicate your answer)

(For office coding: Total Score T____ = ____

+ ____

Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an
educational grant from Pfizer Inc. No permission required to reproduce, translate, display or distribute.

+

____ )

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

99

APPENDIX I
PHQ-9 Scale

PATIENT HEALTH QUESTIONNAIRE-9
(PHQ-9)
Over the last 2 weeks, how often have you been bothered
by any of the following problems?
(Use “ ” to indicate your answer)

Not at all

Several
days

More
than half
the days

Nearly
every
day

1. Little interest or pleasure in doing things

0

1

2

3

2. Feeling down, depressed, or hopeless

0

1

2

3

3. Trouble falling or staying asleep, or sleeping too much

0

1

2

3

4. Feeling tired or having little energy

0

1

2

3

5. Poor appetite or overeating

0

1

2

3

6. Feeling bad about yourself — or that you are a failure or
have let yourself or your family down

0

1

2

3

7. Trouble concentrating on things, such as reading the
newspaper or watching television

0

1

2

3

8. Moving or speaking so slowly that other people could have
noticed? Or the opposite — being so fidgety or restless
that you have been moving around a lot more than usual

0

1

2

3

9. Thoughts that you would be better off dead or of hurting
yourself in some way

0

1

2

3

FOR OFFICE CODING

0

+ ______ + ______ + ______
=Total Score: ______

If you checked off any problems, how difficult have these problems made it for you to do your
work, take care of things at home, or get along with other people?
Not difficult
at all

Somewhat
difficult

Very
difficult

Extremely
difficult

Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from
Pfizer Inc. No permission required to reproduce, translate, display or distribute.
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APPENDIX J
Patient Questionnaire

Please answer the following questions about yourself.
1.) Do you perform any type of physical activity or exercise? Ex: swimming, running,
walking, biking, weight training
Yes

No

If no, skip to question 6
2.) If so, what type of exercise?
_____________________________________________
3.) How many times a week do you perform this exercise?
_____________________________________________
4.) For how many minutes?
_____________________________________________
5.) Would you consider this exercise mild, moderate or strenuous?
Mild

Moderate

Strenuous

6.) Do you perform any relaxation techniques? Ex: progressive muscle relaxation,
meditation, deep breathing, yoga
Yes

No

If no, skip to question 9
7.) If so, how many times a week do you perform relaxation techniques?
_____________________________________________
8.) For how many minutes?
_____________________________________________

100

IMPLEMENTING A GENERALIZED ANXIETY DISORDER PROTOCOL

101

9.) Do you use any form of cognitive behavioral therapy? Ex: smartphone applications or
face to face?
Yes
No
10.)

If so, how many times a day do you perform cognitive behavioral therapy?

_____________________________________________
11.)

For how many minutes?

_____________________________________________
12.)
Do you use benzodiazepine medications such as alprazolam (Xanax) or lorazepam
(Ativan) or diazepam (Valium) or clonazepam (Klonopin)?
Yes
13.)

No

If so, what is the medication that you use and at what dose?

______________________________________________
14.)

How many times per week do you use this medication?

______________________________________________

